Published Research

Scientific research is extremely important in improving the treatment and curability of PMP, appendix cancer, and related peritoneal surface malignancies. Following are some of the pertinent research studies that have been published from 2005 to present. * Research marked with an asterisk was partially or wholly funded by an ACPMP Research Grant

Staged Colectomy May Be Preferable to Upfront Colectomy in Appendix Cancer

Waheed MT, Malik I, Ituarte PHG, et al. Upfront colectomy vs. initial appendectomy followed by completion colectomy for appendiceal cancer: comparison of outcomes. Presented at the 2025 Society of Surgical Oncology Annual Meeting; March 27-29, 2025; Tampa, FL.

Appendix Cancer Is Not the Same as Colorectal Cancer: Implications for Systemic Chemotherapy

Shen, J. P., & Foote, M. B. (2025, March 27). Appendix cancer is not the same as colorectal cancer: Implications for systemic chemotherapy. ASCO Daily News. https://dailynews.ascopubs.org/do/appendix-cancer-not-same-colorectal-cancer-implications-systemic-chemotherapy

A sequence context-based approach for classifying tumor structural variants without paired normal samples

Chukwu, Wolu et al., Cell Report Methods, Volume 0, Issue 0, 100991, PDF Version

Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma

Dansby J, More A, Zeineddine M, Yousef A, Bent A, Dayyani F, Wolff R, Overman M, Shen JP. Taxane-Based Chemotherapy Is Effective in Metastatic Appendiceal Adenocarcinoma. Oncologist. 2023 Dec 11;28(12):e1303-e1305. doi: 10.1093/oncolo/oyad263. PMID: 37738316; PMCID: PMC10712908.

The Landscape of Circulating Tumor DNA (ctDNA) in Appendiceal Adenocarcinoma

White MG, Zeineddine MA, Fallon EA, Zeineddine FA, Dansby J, Chowdhury S, Hornstein N, Yousef A, Yousef M, Bhutiani N, Gu Y, Kee B, Dasari A, Overman MJ, Raghav K, Kopetz S, Uppal A, Taggart M, Newhook T, Fournier K, Helmink B, Drusbosky LM, Shen JP. The Landscape of Circulating Tumor DNA (ctDNA) in Appendiceal Adenocarcinoma. Clin Cancer Res. 2024 Dec 16. doi: 10.1158/1078-0432.CCR-24-2474. Epub ahead of print. PMID: 39679931.

Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: Results from a structured surveillance programme

Hannan E, Roman LM, O’Brien L, Mueller A, Staunton O, Shields C, et al. Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: Results from a structured surveillance programme. Colorectal Dis. 2024; 00: 1–9. https://doi.org/10.1111/codi.17266

Comparison of functional characterization of cancer stem cells in different tumor tissues of pseduomyxoma peritonei

Zhou, H., Xu, H., Pang, S. et al. Comparison of functional characterization of cancer stem cells in different tumor tissues of pseudomyxoma peritonei. J Transl Med 22, 1022 (2024). https://doi.org/10.1186/s12967-024-05730-6

Mortality risk prediction for primary appendiceal cancer

Winicki NM, Radomski SN, Ciftci Y, Sabit AH, Johnston FM, Greer JB. Mortality risk prediction for primary appendiceal cancer. Surgery. 2024 Jun;175(6):1489-1495. doi: 10.1016/j.surg.2024.02.014. Epub 2024 Mar 16. PMID: 38494390.

Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies

Tsagkalidis V, Choe JK, Beninato T, Eskander MF, Grandhi MS, In H, Kennedy TJ, Langan RC, Maggi JC, Pitt HA, Alexander HR, Ecker BL. Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies. Ann Surg Oncol. 2024 Jul;31(7):4203-4212. doi: 10.1245/s10434-024-15233-9. Epub 2024 Apr 9. PMID: 38594579; PMCID: PMC11164803.

What is the optimum post treatment surveillance imaging protocol for low grade appendiceal mucinous neoplasms and pseudomyxoma peritoneii?

Dempsey PJ, Power JW, Yates AH, Martín-Román L, Aird JJ, Mulsow J, Fenlon HM, Cronin CG. What is the optimum post treatment surveillance imaging protocol for low grade appendiceal mucinous neoplasms and pseudomyxoma peritoneii? Br J Radiol. 2024 May 15:tqae102. doi: 10.1093/bjr/tqae102. Epub ahead of print. PMID: 38749003.

Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients

Sugarbaker PH, Chang D. Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients. J Surg Oncol. 2024 May 16. doi: 10.1002/jso.27682. Epub ahead of print. PMID: 38752445.

Cellularity of mucus is a prognostic variable in low-grade appendiceal mucinous neoplasms

Sugarbaker PH, Liang JJ, Deng T, Chang D. Cellularity of mucus is a prognostic variable in low-grade appendiceal mucinous neoplasms. Eur J Surg Oncol. 2024 May 1;50(7):108373. doi: 10.1016/j.ejso.2024.108373. Epub ahead of print. PMID: 38761511.

Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers

Belmont E, Bansal VV, Yousef MMG, Zeineddine MA, Su D, Dhiman A, Liao CY, Polite B, Eng OS, Fournier KF, White MG, Turaga KK, Shen JP, Shergill A. Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers. JCO Precis Oncol. 2024 May;8:e2300531. doi: 10.1200/PO.23.00531. PMID: 38723230.

Superiority of 18F-FAPI-42 PET/CT in the detection of primary tumor and management of appendiceal neoplasm to 18F-FDG PET/CT and CE-CT

Dong, Y., Huang, S., Wu, H. et al. Superiority of 18F-FAPI-42 PET/CT in the detection of primary tumor and management of appendiceal neoplasm to 18F-FDG PET/CT and CE-CT. Cancer Imaging 24, 58 (2024). https://doi.org/10.1186/s40644-024-00706-7

Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

Dadgar, N., Sherry, C., Zimmerman, J. et al. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis. J Transl Med 22, 402 (2024). https://doi.org/10.1186/s12967-024-05205-8

Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma

Hornstein NJ, Zeineddine MA, Gunes BB, Pellatt AJ, Knafl M, Zhu H, Willett AF, Yousef A, Liu S, Sun R, Futreal A, Woodman SE, Taggart MW, Overman MJ, Halperin DM, Raghav KP, Shen JP. Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma. Cancer Res Commun. 2024 May 29;4(5):1363-1368. doi: 10.1158/2767-9764.CRC-24-0019. PMID: 38709066; PMCID: PMC11135244.

Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer

Wajih, N., Erali, R.A., Forsythe, S.D. et al. Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15355-0

Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial

Lidia Rodríguez-Ortiz, Mari C Vázquez-Borrego, Florina I Bura, Melissa Granados-Rodríguez, Francisca Valenzuela-Molina, Blanca Rufián-Andújar, Ana Martínez-López, Rosa Ortega-Salas, Juan José Espejo-Herrero, Antonio Romero-Ruiz, Álvaro Arjona-Sánchez, Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial, British Journal of Surgery, Volume 111, Issue 3, March 2024, znae045, https://doi.org/10.1093/bjs/znae045

Serum Tumor Markers & Outcomes in Patients With Appendiceal Adenocarcinoma

Yousef A, Yousef M, Zeineddine MA, et al. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open. 2024;7(2):e240260. doi:10.1001/jamanetworkopen.2024.0260

Bland–Altman agreement analysis between CT predicted and surgical peritoneal cancer index in pseudomyxoma peritonei of appendiceal origin.

Bai, M., Chen, J., Xu, Y. et al.  Sci Rep 13, 21520 (2023). https://doi.org/10.1038/s41598-023-48975-9

Effects of a Cognitive Behavioral Digital Therapeutic on Anxiety and Depression Symptoms in Patients With Cancer: A Randomized Controlled Trial

Sean R. Zion, Chloe J. Taub, Lauren C. Heathcote, Allison Ramiller, Stacey Tinianov, Michael McKinley, Geoff Eich, Frank J. Penedo, Patricia A. Ganz, Michael Antoni, and Dianne M. Shumay

JCO Oncology Practice 0 0:0

Surgical management of peritoneal metastasis: Opportunities for pharmaceutical research

Michael G. Wientjes, Ze Lu, Carlos H.F. Chan, Kiran Turaga, Jessie L.S. Au,

Journal of Controlled Release,Volume 361, 2023

Defining a role for systemic chemotherapy in local and advanced appendix adenocarcinoma

M.C. Strach, B. Chakrabarty, R.T. Nagaraju, S. Mullamitha, M. Braun, S.T. O’Dwyer, O. Aziz, J. Barriuso

ESMO Open, Volume 8, Issue 5,

Palbociclib as a Novel Therapy for Low-Grade Mucinous Carcinomatosis Peritonei of Appendiceal Origin

Betzaira G. Childers, Divya Sood, Rohini Patel, Evangeline S. Mose, Mojgan Hosseini, Shumei Kato, Joel M. Baumgartner, and Andrew M. Lowy

JCO Precision Oncology 2021 :5, 1069-1072

Low grade appendiceal mucinous neoplasm metastatic to the ovary: A case report and intraoperative assessment guide – PubMed

Nguyen CGT, Hamid A, Chen A, Sood D, Jou J. Low grade appendiceal mucinous neoplasm metastatic to the ovary: A case report and intraoperative assessment guide. Int J Surg Case Rep. 2023 Jul 26;109:108563. doi: 10.1016/j.ijscr.2023.108563. Epub ahead of print. PMID: 37524024.

Appendiceal Signet Ring Cell Carcinoma: An Atypical Cause of Acute Appendicitis—A Case Study and Review of Current Knowledge

Andjelkovic B, Stojanovic B, Stojanovic MD, Milosevic B, Cvetkovic A, Spasic M, Jakovljevic S, Cvetkovic D, Stojanovic BS, Milosev D, et al. Diagnostics. 2023; 13(14):2359. https://doi.org/10.3390/diagnostics13142359

Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma | Cancer Research | American Association for Cancer Research

Ichiaki Ito, Abdelrahman M.G. Yousef, Saikat Chowdhury, Princess N. Dickson, Zahra Alavi. Naini, Michael G. White, Karianne Giller. Fleten, Kjersti Flatmark, Keith F. Fournier, Natalie W. Fowlkes, John Paul. Shen;  Cancer Res 2023

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

Pinto e Vairo, F., Kemppainen, J.L., Vitek, C.R.R. et al. Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD). J Transl Med 21, 410 (2023). https://doi.org/10.1186/s12967-023-04183-7

Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer
Harshabad Singh, Samuel J. Klempner, Nelya Melnitchouk, Deepak P. Chander, Ovidiu George Negrea, Anuj K. Patel, Benjamin L. Schlechter, Douglas A. Rubinson, Brandon M. Huffman, Chetan Nambiar, Joshua Remland, Elizabeth Andrews, Megan E. Leahy, Lauren K. Brais, Peter C. Enzinger, Harvey J. Mamon, Marios Giannakis, Jeffrey A. Meyerhardt, Kimmie Ng, Kimberly J. Perez, Andrew J. Aguirre, Jeffrey W. Clark, James M. Cleary, and Brian M. Wolpin

JCO Precision Oncology 2023 :7

Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced Cancer

Sarah N. Gibbs, Desi Peneva, Gebra Cuyun Carter, Melanie R. Palomares, Snehal Thakkar, David W. Hall, Hannah Dalglish, Cynthia Campos, and Irina Yermilov, JCO Precision Oncology 7 (2023), e2200715, PMID: 37285561. DOI: 10.1200/PO.22.00715

Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma
A Randomized Crossover Trial

John Paul Shen, MD1; Abdelrahman M. Yousef, MD1; Fadl A. Zeineddine, MD2; et al, JAMA Netw Open.2023;6(6):e2316161. doi:10.1001/jamanetworkopen.2023.16161

Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms Cristian D Valenzuela, Christopher W Mangieri, Mary Garland-Kledzik, Rohin Gawdi, Gregory Russell, Kathleen C Perry, Konstantinos I Votanopoulos, Edward A Levine, Perry Shen

Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma Ayumi Taguchi, Hirofumi Rokutan, Katsutoshi Oda, Michihiro Tanikawa, Saki Tanimoto, Kenbun Sone, Mayuyo Mori, Tetsushi Tsuruga, Shinji Kohsaka, Kenji Tatsuno, Aya Shinozaki-Ushiku, Kiyoshi Miyagawa, Hiroyuki Mano, Hiroyuki Aburatani, Tetsuo Ushiku, and Yutaka Osuga

Recurrence of initially localized appendiceal mucinous neoplasms after radical resection: survey analysis and literature review Toshiyuki Kitai, Yutaka Yonemura

The Correlation Between Intra-Abdominal Pressure and Tolerance to Postoperative Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Junye Yu, Lifei Yu, Lin Su, and Ying Shi

Radiomics analysis based on CT’s greater omental caking for predicting pathological grading of pseudomyxoma peritonei Nan Zhou, Ruixue Dou, Xichao Zhai, Jingyang Fang, Jiajun Wang, Ruiqing Ma, Jingxu Xu, Bin Cui, and Lei Liang

Current Opinion and Practice on Peritoneal Carcinomatosis Management: The North African Perspective Amine Souadka, Hajar Essangri, Amin Makni, Mourad Abid, Mouna Ayadi, Feriel Ksantini, Zakia Kordjani, Yousri Ballah, Jemila Bouka, Amine Benkabbou, Mohammed Anass Majbar, Basma El Khannoussi, Raouf Mohsine, Saber Boutayeb, and Martin Hubner

Enhanced computed tomography imaging features predict tumor grade in pseudomyxoma peritonei Pengtao Sun, Xinbao Li, Lingling Wang, Rengui Wang, and Xuechao Du

Significance of the Entire Appendiceal Evaluation in the Diagnosis of Serrated Lesions, Low-Grade Appendiceal Mucinous Neoplasm, and Appendiceal Diverticulosis Disease Fang Li, Yiyan Lu, Fang Hou, Ruiqing Ma, Dezhong Wang, and Changhai Qi

Low-grade appendiceal mucinous neoplasm (LAMN) as a mimicker of perforated diverticulitis: a case report Christopher Shean, Janaka Balasooriya, and James Fergusson

Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix Felipe Lopez-Ramirez, Vadim Gushchin, Michelle Sittig, Mary Caitlin King, Ekaterina Baron, Andrei Nikiforchin, Carol Nieroda, Armando Sardi

Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei Andre Lopes, Evandro Sobroza de Mello, Rossana Veronica Mendoza Lopez, Paulo Cesar Leonardi, Ulysses Ribeiro Jr

Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei Michael P Flood, Joseph C Kong, Toan Pham, Peadar S Waters, Mikael Soucisse, Robert Ramsay, Hui-Li Wong, Catherine Mitchell, Michael Michael, Jacob J McCormick, Satish K Warrier, Tim Akhurst, Alexander G Heriot

Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experience Xavier Fung, I Chuan Li, Kandiah Chandrakumaran, Tom Cecil, Sanjeev Dayal, Alexios Tzivanakis, Brendan Moran, Faheez Mohamed

Multiple intestinal hemangioma concurrent with low-grade appendiceal mucinous neoplasm presenting as intussusception—a case report and literature review Yanhua Yang, Dongmei Jia, and Chen Jiang

The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study Kevin Ke, Krishna Pillai, Ahmed H. Mekkawy, Javed Akhter, Samina Badar, Sarah J. Valle, and David L. Morris

Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya, Hiroshi Yoshida, Tohru Kiyono, Yutaka Yonemura, and Tadashi Kondo

Progression of perforated cystadenoma of the appendix to pseudomyxoma peritonei over 18 years: A case report Paul H Sugarbaker

Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation Anais Alonso, Shoma Barat, Helen Kennedy, Meredith Potter, Nayef Alzahrani, and David Morris

A Rare Case of Psoas Abscess Secondary to Mucinous Adenocarcinoma of the Appendix: A Case Report Rudra M Prabhu, Spandan R Koshire, and R C S Khandelwal

Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy Jesper Nors, Lene Hjerrild Iversen, Karsten Nielsen, Mette Møller Sørensen, Victor Jilbert Verwaal, Jonas Amstrup Funder

Systemic metastases from low-grade and high-grade pseudomyxoma peritonei: Treatments and outcomes Dario Baratti, Pamela Milito, Shigeki Kusamura, Lorena Martin Roman, Marcello Guaglio, Marcello Deraco

Peptide Vaccine Targeting Mutated GNAS: A Potential Novel Treatment for Pseudomyxoma Peritonei Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten, Ben Davidson, Hedvig V Juul, Nadia Mensali, Christin Lund-Andersen, Else Marit Inderberg

The many faces of intraperitoneal chemotherapy Hisham Abdel Mageed, Kurt Van Der Speeten, Paul Sugarbaker

Novel Perspectives in Pseudomyxoma Peritonei Treatment Antonio Sommariva, Marco Tonello, Giulia Rigotto, Nayana Lazzari, Pierluigi Pilati, Maria Luisa Calabrò

Tumor-stroma ratio as a new prognosticator for pseudomyxoma peritonei: a comprehensive clinicopathological and immunohistochemical study Ru Ma, Yu-Lin Lin, Xin-Bao Li, Feng-Cai Yan, Hong-Bin Xu, Zheng Peng, Yan Li

The Clinical Desire for Pressurized Intraperitoneal Aerosol Chemotherapy in South Korea: An Electronic Survey-based Study Eun Ji Lee, Soo Jin Park, Jeesun Lee, Jaehee Mun, Haerin Paik, Aeran Seol, Junhwan Kim, Ga Won Yim, Seung-Hyuk Shim, Hee Seung Kim, Suk-Joon Chang, KoRIA Trial Group

Overall Survival is More Closely Associated with Peritoneal than Primary Appendiceal Pathological Grade in Pseudomyxoma Peritonei with Discordant Pathology Ayaz Ahmed Memon, Chintamani Godbole, Tom Cecil, Sanjeev Dayal, Brendan Moran, Alexios Tzivanakis, Faheez Mohamed, Norman J Carr

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei Lei Liang, Jingyang Fang, Xuedi Han, Xichao Zhai, Yan Song, Yiyan Lu, Qian Zhang, Ruiqing Ma

Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) Jean-Baptiste Delhorme, Laurent Villeneuve, Olivier Bouché, Gerlinde Averous, Anthony Dohan, Jean-Marc Gornet, Benoit You, Frédéric Bibeau, Peggy Dartigues, Clarisse Eveno, Juliette Fontaine, Vahan Kepenekian, Marc Pocard, Pascal Rousset, Francois Quenet, Pascale Mariani, Olivier Glehen, Diane Goéré

Laparoscopic cytoreductive surgery and HIPEC in LAMN with small volume of peritoneal disease: a valuable option of treatment for good patient-related experience measures (PREMs) Caterina Cusumano, Sébastien Carrere, Alix Bouillin, Stéphanie Nougaret, Lakhdar Khellaf, François Quénet, Olivia Sgarbura

Progression to pseudomyxoma peritonei in patients with low grade appendiceal mucinous neoplasms discovered at time of appendectomy Shelby Reiter, Colin J Rog, Mohamed Alassas, Evan Ong

Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination Mason Vierra, Ankit Dhiman, Hunter D D Witmer, Leah Ulrich, Enal Hindi, Emily Fenton, Ardaman Shergill, Blase Polite, Oliver S Eng, Kiran K Turaga

Controversies in appendiceal pathology: Mucinous and goblet cell neoplasms Christine E Orr, Rhonda K Yantiss

Peritoneal Spread of Low-grade Appendiceal Tumours – 2 Days of Early Postoperative Intra-peritoneal Chemotherapy Are Enough Apoorva Rao, Jasmine Mui, Shoma Barat, Amer A Matar, Nayef Alzahrani, David L Morris

Disparities in the Management of Peritoneal Surface Malignancies Kathleen Marulanda, Ugwuji N Maduekwe

Establishing Novel Molecular Subtypes of Appendiceal Cancer Mary Garland-Kledzik, Anthony Scholer, Miquel Ensenyat-Mendez, Javier I J Orozco, Adam Khader, Juan Santamaria-Barria, Trevan Fischer, Alessio Pigazzi, Diego M Marzese

The Biological Synthesis and the Function of Mucin 2 in Pseudomyxoma Peritonei Yu-Lin Lin, Yan Li

*Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei Kjersti Flatmark, Annette Torgunrud, Karianne G Fleten, Ben Davidson, Hedvig V Juul, Nadia Mensali, Christin Lund-Andersen, Else Marit Inderberg

Which classification system defines best prognosis of mucinous neoplasms of the appendix with peritoneal dissemination: TNM vs PSOGI? Lorena Martín-Román, Pablo Lozano, Yesica Gómez, María Jesús Fernández-Aceñero, Wenceslao Vasquez, Natividad Palencia, Luis González-Bayón

Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative Wasay Nizam, Nadege Fackche, Bernardo Pessoa, Boateng Kubi, Jordan M Cloyd, Travis Grotz, Keith Fournier, Sean Dineen, Jula Veerapong, Joel M Baumgartner, Callisia Clarke, Sameer H Patel, Gregory C Wilson, Laura Lambert, Daniel E Abbott, Kara A Vande Walle, Byrne Lee, Mustafa Raoof, Shishir K Maithel, Maria C Russell, Mohammad Y Zaidi, Fabian M Johnston 1, Jonathan B Greer

Enhanced recovery after surgery promotes the postoperative recovery of lung and gastrointestinal function of pseudomyxoma peritonei Xuechun Kuang, Guie She, Yanhui Shi, Shuang Liu, Lijun Nie, Hongying Tang

Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study C Paasch, G De Santo, H N Gamal-Eldin, M Hünerbein

Grade, Complete Cytoreduction Possibility, and Survival Outcomes of Pseudomyxoma Peritonei Lei Liang, Xuedi Han, Nan Zhou, Hongbin Xu, Jun Guo, Qian Zhang

Frequency and Risk Factors for Metastasis in Newly Diagnosed Appendiceal Carcinoma Ahmed Minhas, JeanMarie Hendrickson, Sohail A Minhas

Differential diagnosis of appendiceal serrated lesions and polyps and low-grade appendiceal mucinous neoplasm: analysis of 88 cases Yiyan Lu, Changhai Qi, Hongbin Xu, Mulan Jin

Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review L Martín-Román, P Lozano, W Vásquez, N Palencia, Y Gómez, M J Fernández-Aceñero, L González-Bayón

Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms Dong-Wook Kang, Baek-Hui Kim, Joon Mee Kim, Jihun Kim, Hee Jin Chang, Mee Soo Chang, Jin-Hee Sohn, Mee-Yon Cho, So-Young Jin, Hee Kyung Chang, Hye Seung Han, Jung Yeon Kim, Hee Sung Kim, Do Youn Park, Ha Young Park, So Jeong Lee, Wonae Lee, Hye Seung Lee, Yoo Na Kang, Younghee Choi, Gastrointestinal Pathology Study Group of the Korean Society of Pathologists

First Report of a Low-Grade Pseudomyxoma peritonei Originating from Gall Bladder Aruna Prabhu, Andreas Brandl, Satoshi Wakama, Shouzou Sako, Haruki Ishibashi, Eisei Nishino, Yutaka Yonemura

Clinical Significance of Lymph Node Dissection and Lymph Node Metastasis in Primary Appendiceal Tumor Patients After Curative Resection: a Retrospective Multicenter Cohort Study Hiroshi Takeyama, Kohei Murata, Takashi Takeda, Makoto Fujii, Yoshinori Kagawa, Hiroshi Kawachi, Tatsuro Yamaguchi, Shingo Noura, Toshiki Masuishi, Akira Inoue, Yasumasa Takii, Takeshi Suto, Kazuhiro Sakamoto, Mitsuyoshi Tei, Mitsuo Kishimoto, Takashi Yao, Kenichi Sugihara

Clinicopathological Features of Low-Grade Appendiceal Mucinous Neoplasms Confined to the Appendix Yiyan Lu, Fang Li, Ruiqing Ma, Lan Fang, Changhai Qi

Risk factors of peritoneal metastasis in primary appendiceal tumor X M Huang, X H Liu, L Y Huang, Z R Cai, Y F Chen, X J Wu

Analysis of correlation factors and risk prediction for acute appendicitis associated with appendiceal neoplasms H C Ma, J H Zhang, Y H Liu, Y Q Duan, L Y Zhang, R Liu, Y C Wang, H Xiao, L G Ma, Z J Wang

Treatment of advanced pseudomyxoma peritonei using cytoreductive surgery including total gastrectomy and perioperative chemotherapy Paul H Sugarbaker, David Chang

Low-grade mucinous appendiceal neoplasm mimicking an ovarian lesion: A case report and review of literature André Luís Borges, Catarina Reis-de-Carvalho, Martinha Chorão, Helena Pereira, and Dusan Djokovic

Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy P A Sutton, S T O’Dwyer J Barriuso , O Aziz, C R Selvasekar, A G Renehan, M S Wilson

Lymph node positivity and association with long-term survival for different histologies of appendiceal cancer Christopher Webb, Yu-Hui Chang, Barbara A Pockaj, Richard J Gray, Chee-Chee Stucky, Nabil Wasif

Clinicopathologic characteristics of appendiceal mucinous tumor misdiagnosed as gynecological neoplasms C Chen, Y Zhang

Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms T Evans, O Aziz, B Chakrabarty, M S Wilson, L Malcomson, C Lavelle, S T O’Dwyer

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysis Mikael L Soucisse, Oliver Fisher, Winston Liauw, Lana Ghanipour, Peter Cashin

ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method Kjersti Flatmark, MD, PhD and Faheez Mohamed

Establishment of patient‐derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5‐fluorouracil Yu‐Lin Lin, Jue Zhang, Feng‐Cai Yan, Xi Jiang, Ru Ma, Zhi‐Ran Yang, Hong‐Bin Xu, Zheng Peng, Qian Chen, and Yan Li

Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791) Shigeki Kusamura, Norfarizan Azmi, Luca Fumagalli, Dario Baratti, Marcello Guaglio, Adalberto Cavalleri, Giulia Garrone, Luigi Battaglia, Francesco Barretta, Marcello Deraco

Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and Surgeons Nima Ahmadi, Danko Kostadinov, Shinichiro Sakata, William Robert Ball, Jamish Gandhi, Norman John Carr, Alexios Tzivanakis, Sanjeev Paul Dayal, Faheez Mohamed, Thomas Desmond Cecil, Brendan John Moran

Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei Anthony R. Lam, Khalil Bazzi, Sarah J. Valle, and David L. Morris

New insights in the pathology of peritoneal surface malignancy Norman John Carr

Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review Christin Lund-Andersen, Annette Torgunrud, Karianne Giller Fleten, and Kjersti Flatmark

Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors Philipp Horvath, Can Yurttas, Stefan Beckert, Alfred Königsrainer, and Ingmar Königsrainer

Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale Yvonne Andersson, Karianne G. Fleten, Torveig W. Abrahamsen, Wenche Reed, Ben Davidson, and Kjersti Flatmark

Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases Suryanarayana Deo, Mukurdipi Ray, Babul Bansal, Sandeep Bhoriwal, Sushma Bhatnagar, Rakesh Garg, Nishkarsh Gupta, Atul Sharma, Lalit Kumar, Sanjay Thulkar, Ekta Dhamija, Sandeep Mathur, and Prasenjit Das

Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study Gang Wang, Qiken Li, and Weiping Chen

*Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study Steven D Forsythe, Richard A Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey, Ralph D’Agostino, Lance D Miller, Perry Shen, Edward A Levine, Shay Soker, Konstantinos I Votanopoulos

Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience Giada Munari, Gianluca Businello, Paola Mattiolo, Gianmaria Pennelli, Marta Sbaraglia, Chiara Borga, Salvatore Pucciarelli, Gaya Spolverato, Claudia Mescoli, Francesca Galuppini, Antonio Sommariva, Elena Bellan, Sara Lonardi, Fotios Loupakis, Claudio Luchini, Angelo Paolo Dei Tos, Matteo Fassan

Clinicopathological Characteristics of Low-Grade Appendiceal Mucinous Neoplasm Tatsuro Yamaguchi, Kohei Murata, Tetsuya Shiota, Hiroshi Takeyama, Shingo Noura, Kazuhiro Sakamoto, Takeshi Suto, Yasumasa Takii, Toshiya Nagasaki, Takashi Takeda, Makoto Fujii, Yoshinori Kagawa, Tsunekazu Mizushima, Yuko Ohno, Takashi Yao, Mitsuo Kishimoto, Kenichi Sugihara, Study Group of Appendiceal Neoplasms in the JSCCR

Epidemiology, histopathology, clinical outcomes and survival of 50 cases of appendiceal mucinous neoplasms: Retrospective cross-sectional single academic tertiary care hospital experience Ammar Aleter, Walid El Ansari, Ali Toffaha, Adham Ammar, Fakhar Shahid, and Abdelrahman Abdelaal

Histologic and racial/ethnic patterns of appendiceal cancer among young patients Timothy Gibbs, Mary K Washington, Cathy Eng, Kamran Idrees, Jamaine Davis, Andreana N Holowatyj

A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery Satoshi Hirano, Yoshimasa Gohda, Hideki Miyazaki, Nami Hayama, Shinichiro Shimizu, Toru Igari, Hideaki Yano

Risk of appendiceal neoplasm after interval appendectomy for complicated appendicitis: A systematic review and meta-analysis Roberto Peltrini, Valeria Cantoni, Roberta Green, Ruggero Lionetti, Michele D’Ambra, Carolina Bartolini, Marcello De Luca, Umberto Bracale, Alberto Cuocolo, Francesco Corcione

Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines Yu-Lin Lin, Da-Zhao Xu, Xin-Bao Li, Feng-Cai Yan, Hong-Bin Xu, Zheng Peng, and Yan Li

Western Australian Peritonectomy Service: a review of the first 6 years of operation of a low-volume peritonectomy centre Phillip McEntee Simon Keelan, Paul Salama, Paul Moroz

Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index Bertrand Trilling, Alexandre Brind’Amour, Raphael Hamad, Jean-Francois Tremblay, Pierre Dubé, Andrew Mitchell, and Lucas Sidéris

Evaluation of the significance of pseudomyxoma peritonei patients based on the Peritoneal Surface Oncology Group International (PSOGI) classification Jong Lyul Lee, Meejeong Kim, Jihun Kim, Chan Wook Kim, Ye Jin Ha, Seon-Young Kim, Dong-Hyung Cho, Jin Cheon Kim

From Diagnosis to Management; Mucocele of Stump Appendicitis, Extremely Rare Finding in an Uncommon Surgical Disease: Literature Review Syed Muhammad Ali, Mohannad Al-Tarakji, Fakhar Shahid, Amjad Salah Qabani, Amjad Ali Shah, Khalid Ahmed, Muhammad Burhan Khan, and Inamullah

Single-incision laparoscopic surgery compared to conventional laparoscopic surgery for appendiceal mucocele: a series of 116 patients Ho Seung Kim, Han-Gil Kim, Seung Yoon Yang, Yoon Dae Han, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim, Min Soo Cho

The Frontiers of Appendiceal Controversies: Mucinous Neoplasms and Pseudomyxoma Peritonei Erika Hissong, Rhonda K Yantiss

Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report F Lococo, A Di Giorgio, A Iaffaldano, G Schinzari, D Tabacco, P Aceto, C Abatini, L Sollazzi, S Margaritora

From the Ronnett to the PSOGI Classification System for Pseudomyxoma Peritonei: A Validation Study Blanca Rufián-Andujar, Francisca Valenzuela-Molina, Sebastián Rufián-Peña, Ángela Casado-Adam, Juan Manuel Sánchez-Hidalgo, Lidia Rodríguez-Ortiz, Francisco Javier Medina-Fernández, Cesar Díaz-López, Rosa Ortega-Salas, Ana Martínez-López, Javier Briceño-Delgado, Antonio Romero-Ruíz, Álvaro Arjona-Sánchez

A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms Joel M Baumgartner, Amitabh Srivastava, Nelya Melnitchouk, Michael G Drage, Aaron R Huber, Raul S Gonzalez, Phoenix Bell, Elizabeth Wu, Murray Resnick, Kiran Turaga, Elizabeth Poli, Jesus Esquivel, Jeremiah Deneve, Kaitlyn J Kelly, Jula Veerapong, Andrew M Lowy

Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery Christopher P. Scally, MD; Keith F. Fournier, MD; Paul F. Mansfield, MD

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery Shigeki Kusamura, Francesco Barretta, Yutaka Yonemura, Paul Hendrick Sugarbaker, Brendan John Moran, Edward A Levine, Diane Goer, Dario Baratti, Eran Nizri, David Lawson Morris, Olivier Glehen, Armando Sardi, Pedro Barrios, François Quénet, Laurent Villeneuve, Alberto Gómez-Portilla, Ignace de Hingh, Wim Ceelen, Joerg O W Pelz, Pompiliu Piso, Santiago González-Moreno, Kurt Van Der Speeten, Marcello Deraco, Peritoneal Surface Oncology Group International (PSOGI) and the French National Registry of Rare Peritoneal Surface Malignancies (RENAPE)

Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer Kanwal Raghav, John P. Shen, Alexandre A. Jácome, Jennifer L. Guerra, Christopher P. Scally, Melissa W. Taggart, Wai C. Foo, Aurelio Matamoros, Kenna R. Shaw, Keith Fournier, Michael J. Overman, and Cathy Eng

Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei Sakura Hiraide, Keigo Komine, Yuko Sato, Kota Ouchi, Hiroo Imai, Ken Saijo, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, and Chikashi Ishioka

A Case of Appendix Torsion with Low-Grade Appendiceal Mucinous Neoplasm Nobuo Takiguchi, Hideo Ota, Tomohira Takeoka, Kazuma Ito, Hidetaka Miyazaki, Hiroki Ueda, Shigeto Nakai, Hiroshi Matsuno, Ken Konishi, Kazuyuki Okada, Shigekazu Yokoyama, Mutsumi Fukunaga

Germline and somatic genetic alterations in two first‐degree relatives with appendiceal low‐grade mucinous carcinoma peritonei Mary Caitlin King, Carlos Munoz‐Zuluaga, Panayotis Ledakis, Kimberley Studeman, Michelle Sittig, Vadim Gushchin, and Armando Sardi

Peritoneal pseudomyxoma after incomplete appendectomy Dahbia Djelil, Anthony Dohan, and Marc Pocard

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry A Arjona-Sanchez, O Aziz, G Passot, G Salti, J Esquivel, K Van der Speeten, P Piso, S Nedeclut, A Sommariva, Y Yonemura, K Turaga, C R Selvasekar, L Rodriguez-Ortiz, J M Sanchez-Hidalgo, A Casado-Adam, S Rufian-Peña, J Briceño, O Glehen

The Prognostic Impact of Pathology on Patients With Pseudomyxoma Peritonei Undergoing Debulking Surgery: A Systematic Review and Meta-Analysis of Retrospective Studies Shengnan Zhou, Huaiyu Zhao, and Xiaodong He

Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Niharika Rajan Garach, Shigeki Kusamura, Marcello Guaglio, Valentina Bartolini, Marcello Deraco, Dario Baratti

Predictors of Progression of Appendiceal Mucinous Neoplasm to Pseudomyxoma Peritonei Stefanie Sueda, Stephanie Young, Michael Sung, Mayo Hotta, Victoria O’Connor, Anna M Leung

Risk Factors for Appendiceal Cancer After Appendectomy Stephen J Stopenski, Areg Grigorian, Joseph Carmichael, Steven Mills, Matthew Brady, Matthew Dolich, Catherine M Kuza, Ninh T Nguyen, Jeffry Nahmias

Spectrum of Somatic Cancer Gene Variations Among Adults With Appendiceal Cancer by Age at Disease Onset Andreana N. Holowatyj, PhD, MS, Cathy Eng, MD, Wanqing Wen, MD, Kamran Idrees, MD, MS, MMHC, and Xingyi Guo, PhD

Impact of signet ring cells on overall survival in peritoneal disseminated appendix cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Raphael Shamavonian, Joshua D Lansom, Josh B Karpes, Nayef A Alzahrani, David L Morris

Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments Maria Luisa Calabrò, Nayana Lazzari, Giulia Rigotto, Marco Tonello, and Antonio Sommariva

Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles Wei Pei, Sicheng Zhou, Jing Zhang, Haitao Zhou, Haipeng Chen, Jianjun Bi, Zhaoxu Zheng, Zheng Liu, Zheng Jiang, Zheng Wang, Qian Liu, Xishan Wang, Jianwei Liang, and Qiang Feng

Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours Amit Sarka, Joshua Lansom, Anindita Dey, Oliver Fisher, Nayef Alzahrani, David L Morris

Incidental low grade mucinous neoplasm of appendix in pregnancy: A case report & literature review Nitasha Saleem, Fakhar Shahid, Syed Mohammed Ali, Sameera Rashid, Mohannad Al-Tarakji, and Mohammad Sameer

Mode of Presentation in 1070 Patients With Perforated Epithelial Appendiceal Tumors, Predominantly with Pseudomyxoma Peritonei Umar S Shariff, Kandiah Chandrakumaran, Sanjeev Dayal, Faheez Mohamed, Tom D Cecil, Brendan J Moran

Outcomes of home parenteral nutrition in 34 patients with intestinal failure from recurrent or progressive peritoneal malignancy of gastro-intestinal tract origin David Swain, Gemma Mason, Allison Yates, Sara Burke, Tom Cecil, Faheez Mohamed, Sanjeev Dayal, Alexios Tzivanakis, Brendan Moran

Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer Ashok K Dilly, Brendon D Honick, Robin Frederick, Anuleka Elapavaluru, Sachin Velankar, Hima Makala, T Kevin Hitchens, Lesley M Foley, Jianxia Guo, Jan H Beumer, Lora Heather Rigatti, Yong J Lee, David L Bartlett, Haroon A Choudry

National trends in the presentation of surgically resected appendiceal adenocarcinoma over a decade Adrienne B Shannon, Yun Song, Robert E Roses, Douglas L Fraker, John T Miura, Giorgos C Karakousis

Gross mucinous multinodular appearance aids in the identification of ovarian metastases in low-grade appendiceal mucinous neoplasms during intraoperative consultation Hiroshi Yoshida, Hiroki Tanaka, Takafumi Tsukada, Naoko Abeto, Mayumi Kobayashi-Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato

PIPAC-OX: A Phase I study of Oxaliplatin-based Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients with Peritoneal Metastases Guowei Kim, Hon Lyn Tan, Raghav Sundar, Bettina Lieske, Cheng Ean Chee, Jingshan Ho, Asim Shabbir, Maria V Babak, Wee Han Ang, Boon Cher Goh, Wei Peng Yong, Lingzhi Wang, Jimmy Bok Yan So

Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review Ekaterina Baron, Vadim Gushchin, Mary Caitlin King, Andrei Nikiforchin, and Armando Sardi

Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms T Evans, O Aziz, B Chakrabarty, M S Wilson, L Malcomson, C Lavelle, S T O’Dwyer

Appendiceal cancer: a review of the literature M Van de Moortele, G De Hertogh, X Sagaert, E Van Cutsem

Appendiceal cancer leading to intussusception detected incidentally during follow-up for Peutz–Jeghers syndrome Kazuhiro Kurihara and Takanori Suganuma

Appendiceal neoplasm incidence and mortality rates are on the rise in Australia Reger R Mikaeel, Joanne P Young, Jennifer E Hardingham, Gonzalo Tapia Rico, Peter J Hewett, Erin L Symonds, Suzanne Edwards, Eric Smith, Yoko Tomita, Wendy Uylaki, Mehgan Horsnell, Timothy J Price

Molecular Characterization of Appendiceal Goblet Cell Carcinoid Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, Natsuko Kawanishi, Jingyuan Wang, Shivani Soni, Wu Zhang, Joshua Millstein, Curtis Johnston, Richard M Goldberg, Philip A Philip, Andreas Seeber, Joanne Xiu, Jimmy J Hwang, Anthony F Shields, John L Marshall, W Michael Korn, Heinz-Josef Lenz

A Unique Case of Low-Grade Mucinous Neoplasm in Stump Appendectomy Mohannad Al-Tarakji, Syed Muhammad Ali,  Amjad Ali Shah, Mahir Abdulla Petkar, Salman Mirza, Rajvir Singh, and Ahmad Zarour

Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years Paul H Sugarbaker

Adult intussusception secondary to an appendiceal tumour in a patient with ulcerative colitis: a case report M. G. Davey, E. T. Conlon, G. Forde, V. M. Byrnes, and P. A. Carroll

What you see might not be what you get: Discrepancies between intraoperative findings and preoperative diagnosis of ovarian tumors. Appendicular mucocele presenting as an adnexal mass – Case report and review of literature Ali Toffaha, Walid El Ansari, and Ammar Aleter

Analysis of Clinicopathological Characteristics of Appendiceal Tumors in Japan: A Multicenter Collaborative Retrospective Clinical Study- A Japanese Nationwide Survey Shimpei Matsui, Kohei Murata, Yosuke Fukunaga, Takashi Takeda, Makoto Fujii, Tatsuro Yamaguchi, Yoshinori Kagawa, Tsunekazu Mizushima, Yuko Ohno, Takashi Yao, Yuichiro Doki, Kenichi Sugihara

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with or without early post-operative intraperitoneal chemotherapy for appendix neoplasms with peritoneal metastases: A propensity score analysis Mikael L Soucisse, Oliver Fisher, Winston Liauw, Lana Ghanipour, Peter Cashin

Clinicopathological Characteristics of Pseudomyxoma Peritonei Originated from Ovaries Fengcai Yan, Feng Shi, Xinbao Li, Chunkai Yu, Yulin Lin, Yan Li, and Mulan Jin

Comparative effectiveness of prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for resected low-grade appendiceal mucinous neoplasm (LAMN) A protocol for systematic review and network meta-analysis Wenming Yang, MD, Pan Nie, MD, Xueting Liu, MS, and Jikui Peng, MD, PhD

Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study Giammaria Fiorentini, Donatella Sarti, Alberto Patriti, Emilio Eugeni, Francesco Guerra, Francesco Masedu, Andrew Reay Mackay, and Stefano Guadagni

Macroscopic and microscopic characteristics of low grade appendiceal mucinous neoplasms (LAMN) on appendectomy specimens and correlations with pseudomyxoma peritonei development risk Kirsten S Hegg, Lloyd A Mack, Antoine Bouchard-Fortier, Walley J Temple, Xianyong Gui

Late stage diagnosis of mucinous adenocarcinoma of the appendix: a case report of an unusual tumor with a rare presentation Katerina Roma, Mark Baldwin, Daniel Sedmak, Matthew Silva, William Stellar, and Gina Many

The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies Mackenzie C Morris, Jordan M Cloyd, John Hays, Sameer H Patel

Molecular and clinicopathological features of appendiceal mucinous neoplasms Yuka Yanai, Tsuyoshi Saito, Takuo Hayashi, Yoichi Akazawa, Noboru Yatagai, Sho Tsuyama, Shigeki Tomita, Shu Hirai, Kanako Ogura, Toshiharu Matsumoto, Ryo Wada, Takashi Yao

Continued increasing incidence of malignant appendiceal tumors in Canada and the United States: A population-based study Harminder Singh, Ananda S Koomson, Kathleen M Decker, Jason Park, Alain A Demers

Immunohistochemical staining as supportive diagnostic tool for pseudomyxoma peritonei arising from intraductal papillary mucinous neoplasm: A report of two cases and literature review Atsuko Kataoka, Kyoji Ito, Nobuyuki Takemura, Fuyuki Inagaki, Fuminori Mihara, Yoshimasa Gohda, Tomomichi Kiyomatsu, Kazuhiko Yamada, Naoki Kojima, Toru Igari, Mitsunori Yamakawa, Hideaki Yano, Norihiro Kokudo

Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach Aruna Prabhu, Andreas Brandl, Satoshi Wakama, Shouzou Sako, Haruaki Ishibashi, Akiyoshi Mizumoto, Nobuyuki Takao, Kousuke Noguchi, Shunsuke Motoi, Masumi Ichinose, Yang Liu, and Yutaka Yonemura

Advances with pharmacotherapy for peritoneal metastasis Yutaka Yonemura, Haruaki Iahibashi, Shouzou Sako, Akiyoshi Mizumoto, Nobuyuki Takao, Masumi Ichinose, Shunsuke Motoi, Yang Liu, Satoshi Wakama, Yasuyuki Kamada, Kazurou Nishihara

Updates in Appendix Pathology: The Precarious Cutting Edge Norman J Carr

Utility of computed tomography and 18 F-fluorodeoxyglucose with positron emission tomography/computed tomography for distinguishing appendiceal mucocele caused by mucinous adenocarcinoma from other pathologies M Kaneko, K Kawai, H Nozawa, K Hata, T Tanaka, T Nishikawa, Y Shuno, K Sasaki, S Emoto, K Murono, H Ishii, H Sonoda, T Watadani, H Takao, O Abe, S Ishihara

Development and validation of prognostic nomograms for pseudomyxoma peritonei patients after surgery: A population-based study Peng Chen, MM, Lan Su, MM, Wenming Yang, MM, Jianhao Zhang, MM, Yong Wang, MD, Cun Wang, MD, Yongyang Yu, MD, Lie Yang, MD, and Zongguang Zhou, MD

Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review Mikael L Soucisse, Joshua Lansom, Mohammad S Alshahrani, David L Morris

*Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPEC Omeed Moaven, MD, Jing Su, PhD, Guangxu Jin, PhD, Konstantinos I. Votanopoulos, MD, PhD, Perry Shen, MD, Christopher Mangieri, MD, Stacey S. O’Neill, MD, PhD, Kathleen C. Perry, MSc, Edward A. Levine, MD, and Lance D. Miller, PhD

Pseudomyxoma Peritonei Originating from Transverse Colon Mucinous Adenocarcinoma: A Case Report and Literature Review Yingbo Gong, Xin Wang, and Zhi Zhu

Invasive Mucinous Neoplasm of the Appendix Masquerading as Recurrent Urinary Tract Infections: a Case Report Maeghan L Ciampa, James P Chohonis, Richard S Otto, Benjamin T Franklin

The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review Yu-Lin Lin, Ru Ma, and Yan Li

Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative Adriana C Gamboa, Rachel M Lee, Michael K Turgeon, Mohammad Y Zaidi, Charles W Kimbrough, Travis E Grotz, Jennifer Leiting, Keith Fournier, Andrew J Lee, Sean P Dineen, Benjamin D Powers, Jula Veerapong, Joel M Baumgartner, Callisia N Clarke, Harveshp Mogal, Sameer H Patel, Tiffany C Lee, Laura A Lambert, Ryan J Hendrix, Daniel E Abbott, Courtney Pokrzywa, Mustafa Raoof, Oliver S Eng, Fabian M Johnston, Jonathan Greer, Jordan M Cloyd, Shishir K Maithel, Charles A Staley

Is interval appendectomy really needed? A closer look at neoplasm rates in adult patients undergoing interval appendectomy after complicated appendicitis Danielle Hayes, Shelby Reiter, Edard Hagen, Gary Lucas, Isabelle Chu, Tobias Muñiz, Ryan Martinez

A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function Jinning Ye, Liuhua Chen, Jidong Zuo, Jianjun Peng, Chuangqi Chen, Shirong Cai, Wu Song, Yulong He, and Yujie Yuan

Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies Katie M Leick, Austin G Kazarian, Maheen Rajput, Ann Tomanek-Chalkley, Ann Miller, Hannah R Shrader, Ashley McCarthy, Kristen L Coleman, Pashtoon M Kasi, Carlos H F Chan

The role of mucin cell-free DNA detection as a new marker for the study of acellular pseudomyxoma peritonei of appendicular origin by liquid biopsy Damián García-Olmo, Susana Olmedillas-López, Delia Cortés-Guiral, Pedro Villarejo, Irene López Rojo, Héctor Guadalajara, Soledad García Gómez-Heras, and Mariano García-Arranz

Surgical management of appendiceal mucinous neoplasm: Is appendectomy sufficient? Stephanie Young, Stefanie K Sueda, Mayo Hotta, Michael L Sung, Victoria V OʼConnor, Anna M Leung

A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Dimitrios Papageorgiou, Dimitrios K Manatakis, Katerina Papakonstantinou, Ioannis D Kyriazanos

*Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform Steven D Forsythe, Shyama Sasikumar, Omeed Moaven, Hemamylammal Sivakumar, Perry Shen, Edward A Levine, Shay Soker, Aleksander Skardal, Konstantinos I Votanopoulos

Outcome of Icelandic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) abroad Astridur Petursdottir, Orvar Gunnarsson, Elsa B Valsdottir

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases – The Hong Kong experience and literature review Felix Che-Lok Chow, Jeremy Yip, Dominic Chi-Chung Foo, Rockson Wei, Hok Kwok Choi, Ka Kin Ng, Oswens Siu-Hung Lo

Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei Yo Kawaguchi, Jun Hanaoka

Early-Onset Appendiceal Cancer Survival by Race or Ethnicity in the United States Andreana N Holowatyj, Kay M Washington, Safia N Salaria, Christopher H Lieu, Kamran Idrees, Cathy Eng

Complete pathological response of high grade appendicular neoplasm induced Pseudomyxoma Peritonei (PMP) after neoadjuvant intra-peritoneal chemotherapy: A case report Naveen Padmanabhan, Haruaki Ishibashi, Kazurou Nishihara, Shouzou Sako, Kanji Katayama, Satoshi Wakama, Yasuyuki Kamada, Yutaka Yonemura

Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles Claudio Isella, Marco Vaira, Manuela Robella, Sara Erika Bellomo, Gabriele Picco, Alice Borsano, Andrea Mignone, Consalvo Petti, Roberta Porporato, Alexandra Ambra Ulla, Alberto Pisacane, Anna Sapino, Michele De Simone, and Enzo Medico

Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept Olivia Sgarbura, Mohammed Al Hosni, Andrea Petruzziello, Rodrigo Figueroa, Lakhdar Khellaf, Marie-Hélène Pissas, Sébastien Carrère, Stephanie Nougaret, Frédéric Bibeau 8, François Quénet

Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method Thale Dawn J. H. Patrick-Brown, MSc, Norman John Carr, MD, PhD, David M. Swanson, PhD, Stein Larsen, MD, PhD, Faheez Mohamed, MD, PhD, and Kjersti Flatmark, MD, PhD

ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method Kjersti Flatmark, MD, PhD and Faheez Mohamed, MD, FRCS

Peritoneal carcinomatosis of unknown primary site, a study of 25 patients over 30 years Paul H Sugarbaker

Blood‐Based Next‐Generation Sequencing Analysis of Appendiceal Cancers Walid L. Shaib, Katerina Zakka, Charles Staley, III, Ali Roberts, Mehmet Akce, Christina Wu, Olatunji B. Alese, and Bassel F. El‐Rayes

Continued Increasing Incidence of Malignant Appendiceal Tumors in Canada and the United States: A Population-Based Study Harminder Singh, Ananda S Koomson, Kathleen M Decker, Jason Park, Alain A Demers

Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method Thale Dawn J H Patrick-Brown, Norman John Carr, David M Swanson, Stein Larsen, Faheez Mohamed, Kjersti Flatmark

Outcomes in Peritoneal Carcinomatosis From Appendiceal Goblet Cell Carcinoma Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Katherin Zambrano-Vera, Armando Sardi, Carlos Munoz-Zuluaga, Kimberley Studeman, Carol Nieroda, Michelle Sittig, Mary Caitlin King, Arkadii Sipok, Vadim Gushchin

Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) With Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients With Peritoneal Carcinomatosis Ekaterina Baron, Vladimir Milovanov, Vadim Gushchin, Michelle Sittig, Carol Neiroda, Armando Sardi 

Peritoneal Cancers and Hyperthermic Intraperitoneal Chemotherapy Pletcher E, Gleeson E, Labow D

Impact of Mucin Cellularity and Distribution on Survival in Newly Diagnosed Patients with Low-Grade Appendiceal Mucinous Neoplasm Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Nikiforchin A, King MC, Baron E, MacDonald R, Sittig M, Nieroda C, Gushchin V, Sardi A.

Outcomes of Neoadjuvant Chemotherapy Before CRS-HIPEC for Patients With Appendiceal Cancer J C Chen, Eliza W Beal, John Hays, Timothy M Pawlik, Sherif Abdel-Misih, Jordan M Cloyd

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin, Cisplatin, and Doxorubicin in Patients With Peritoneal Carcinomatosis: An Open-Label, Single-Arm, Phase II Clinical Trial Michele De Simone, Marco Vaira, Monica Argenziano, Paola Berchialla, Alberto Pisacane, Armando Cinquegrana, Roberta Cavalli, Alice Borsano, Manuela Robella

Low-Grade Appendiceal Mucinous Neoplasm in an Adolescent Patient With Untreated Crohn’s Disease Stefany Hernández Benabe, MD, Rachel Leeman, MD, Ann C. Brady, MD, Alicia Hirzel, MD, and Amber H. Langshaw

Germline Whole Exome Sequencing of a Family With Appendiceal Mucinous Tumours Presenting With Pseudomyxoma Peritonei Mei Sim Lung , Catherine A Mitchell, Maria A Doyle, Andrew C Lynch, Kylie L Gorringe, David D L Bowtell, Australian Ovarian Cancer Study Group; Ian G Campbell, Alison H Trainer

Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma Adrienne B. Shannon MD, Drew Goldberg BA, Yun Song MD, Emily C. Paulson MD, MSCE, Robert E. Roses MD, Douglas L. Fraker MD, Rachel R. Kelz MD, John Miura MD, Giorgos C. Karakousis MD

Treatment of Primary and Metastatic Peritoneal Tumors in the Covid-19 Pandemic Proposals for Prioritization From the RENAPE and BIG-RENAPE Groups O Glehen, V Kepenekian, O Bouché, L Gladieff, C Honore, Renape- Big-Renape

Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated With Prohibitive Complications: Results of a Multiinstitutional Retrospective Study Benjamin D Powers, Seth Felder, Jula Veerapong, Joel M Baumgartner, Callisia Clarke, Harveshp Mogal, Charles A Staley, Shishir K Maithel, Sameer Patel, Vikrom Dhar, Laura Lambert, Ryan J Hendrix, Daniel E Abbott, Courtney Pokrzywa, Mustafa Raoof, Byrne Lee, Fabian M Johnston, Jonathan Greer, Jordan M Cloyd, Charles Kimbrough, Travis Grotz, Jennifer Leiting, Keith Fournier, Andrew J Lee, Iman Imanirad, Sophie Dessureault, Sean P Dineen

Primary Low-Grade Mucinous Adenocarcinoma Spleen Resulting in Pseudomyxoma Peritonei: A Case Report Bhumika Gupta , Richa Jindal, Molly Joseph, Kuldeep Kaur, Shikha Chopra, Lipakshi Lakhiani

Appendiceal Adenocarcinoma Associated With Ulcerative Colitis Fredy Nehme, Ashley Schneider, and Fadi Hamid

Postoperative pain pathophysiology and treatment strategies after CRS + HIPEC for peritoneal cancer Xiao Wang and Tianzuo Li

Clinical Evaluation of Tumor-Stroma Ratio in Pseudomyxoma Peritonei From the Appendix R Ma, X B Li, F C Yan, Y L Lin, Y Li

The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms Chicago Consensus Working Group: Darryl Schuitevoerder, Alejandro Plana, Francisco J Izquierdo, Konstantinos I Votanopoulos, James C Cusack Jr, Lana Bijelic, Clifford S Cho, Alexandra Gangi, Erin W Gilbert, Martin D Goodman, Anand Govindarajan, Vadim Gushchin, Chukwuemeka Ihemelandu, Kaitlyn J Kelly, Ryan P Merkow, Sam G Pappas, Daniel E Abbott, Steven A Ahrendt, Mazin Al-Kasspooles, Lindsay Alpert, Farin Amersi, Amanda K Arrington, Brian Badgwell, Robert M Barone, Joel M Baumgartner, Dan G Blazer 3rd, Richard N Berri, Charles Komen Brown, Daniel V Catenacci, Carlos H F Chan, M Haroon A Choudry, Callisia N Clarke, Jordan M Cloyd, Abraham H Dachman, Jeremiah L Deneve, Sean P Dineen, Leopoldo J Fernandez, Oliver S Eng, James W Fleshman Jr, T Clark Gamblin, Georgios V Georgakis, Travis E Grotz, Nader Hanna, Carla Harmath, John Hart, Andrea Hayes-Jordan, Aliya N Husain, Kamran Idrees, Haejin In, David Jiang, John M Kane 3rd, Timothy J Kennedy, Xavier M Keutgen, Hedy Lee Kindler, Byrne Lee, Chih-Yi Liao, Ugwuji N Maduekwe, Grace Z Mak, Lloyd A Mack, Melvy Sarah Mathew, Marcovalerio Melis, Nelya Melnitchouk, Joseph Misdraji, Harveshp Mogal, Mecker G Möller, Garrett M Nash, Aytekin Oto, Reetesh K Pai, Colette R Pameijer, Patricio M Polanco, Blase N Polite, Sanjay S Reddy, Richard Royal, David P Ryan, George Salti, Armando Sardi, Maheswari Senthil, Namrata Setia, Scott K Sherman, Lucas Sideris, Joseph Skitzki, Jula Veerapong, Michael G White, Joshua H Winer, Shu-Yuan Xiao, Rhonda K Yantiss, Nita Ahuja, Wilbur Bowne, Andrew M Lowy, H Richard Alexander Jr, Jesus Esquivel, Jason M Foster, Daniel M Labow, Laura A Lambert, Edward A Levine, Charles Staley, Paul H Sugarbaker, David L Bartlett, Kiran Turaga

A Nomogram for Predicting Lymph Nodal Metastases in Patients With Appendiceal Cancers: An Analysis of SEER Database Dan Wang, Chongshun Liu, Tingyu Yan, Chenglong Li, Cenap Güngör, Qionghui Yang , Yang Xu, Lilan Zhao, Qian Pei, Fengbo Tan, Yuqiang Li

Impact of Adjuvant Chemotherapy on Outcomes in Appendiceal Cancer Bhaskar C Kolla, Ashley Petersen, Madhuri Chengappa, Tulasi Gummadi, Chitra Ganesan, Wolfgang B Gaertner, Anne Blaes

Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review With PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment K Govaerts, R J Lurvink, I H J T De Hingh, K Van der Speeten, L Villeneuve, S Kusamura, V Kepenekian, M Deraco, O Glehen, B J Moran, PSOGI

Pressurized IntraPeritoneal Aerosol Chemotherapy With One Minute of Electrostatic Precipitation (ePIPAC) Is Feasible, but the Histological Tumor Response in Peritoneal Metastasis Is Insufficient Martin Graversen, Sönke Detlefsen, Signe Bremholm Ellebaek, Claus Fristrup, Per Pfeiffer, Michael B Mortensen

Initial Experience of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in a French Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Expert Center C Ceribelli, T Debs, A Chevallier, M A Piche, J M Bereder

A prospective study of discrepancy between clinical and pathological diagnosis of appendiceal mucinous neoplasm Han Deok Kwak and Jae Kyun Ju

Appendix Cancer With Long-Term Survival After Multimodality Therapy-A Case Report Dai Kitagawa, Qingjiang Hu, Kazuki Takada, Hirofumi Hasegawa, Fumiaki Kishihara, Satoru Funahashi, Masayuki Kitamura

A Case of Peritoneal Metastasis of Appendiceal Mucinous Carcinoma Successfully Managed by Multidisciplinary Treatment Eisuke Yamamoto, Yuu Muta, Testuya Itou, Kenichi Chikatani, Azusa Yamamoto, Shunsuke Muramatsu, Yoshitaka Toyomasu, Satoshi Hatano, Okihide Suzuki, Kunihiko Amano, Toru Ishiguro, Youichi Kumagai, Keiichiro Ishibashi, Erito Mochiki, Hideyuki Ishida

A Case of Low-Grade Appendiceal Mucinous Neoplasm Complicated by Pseudomyxoma Peritoneri Successfully Treated With Cytoreductive Surgery and Intraperitoneal Chemotherapy Shinnosuke Sakamoto, Toru Ishiguro, Masumi Kumakura, Hiroyasu Ishikawa, Eisuke Yamamoto, Yuu Muta, Tetsuya Itou, Shunsuke Muramatsu, Yoshitaka Toyomasu, Okihide Suzuki, Youichi Kumagai, Keiichiro Ishibashi, Erito Mochiki, Hideyuki Ishida

Hemodynamic and Respiratory Implications of High Intra-Abdominal Pressure During HIPEC Artur C V Reis, Shigeki Kusamura, Norfarizan Azmi, Luca Fumagalli, Federico Piccioni, Franco Valenza, Dario Baratti, Marcello Guaglio, Adalberto Cavalleri, Giulia Garrone, Francesco Barretta, Marcello Deraco

Continued Increasing Incidence of Malignant Appendiceal Tumors in Canada and the United States: A Population-Based Study Harminder Singh, Ananda S Koomson, Kathleen M Decker, Jason Park, Alain A Demers

Repeat Cytoreductive Surgery With or Without Intraperitoneal Chemotherapy for Recurrent Epithelial Appendiceal Neoplasms J B Karpes, J D Lansom, M Alshahrani, R Parikh, R Shamavonian, N A Alzahrani, W Liauw, D L Morris

Peritoneal Carcinomatosis and Its Mimics: Review of CT Findings for Differential Diagnosis Joon Ho Cho, MD and Seung Soo Kim, MD, PhD

Synchronous Primary Neuroendocrine and Mucinous Epithelial Tumors Present in the Same Appendix. Case Report of 2 Patients. Paul H Sugarbaker, Almog Ben-Yaacov, David Hazzan, Aviram Nissan

Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors? Misbah Yehya, Matthew Denson, and Zbigniew Moszczynski

Pathological Prognostic Factors of Pseudomyxoma Peritonei:Comprehensive Clinicopathological Analysis of 155 Cases Yan F, Lin Y, Zhou Q, Chang H, Li Y

Analysis of Clinical Characteristics of Low-Grade Appendiceal Mucinous Neoplasm (LAMN): A Retrospective Cohort Study of 51 LAMN Patients Xiao J, Li P, Liu W

Pressurized Intraperitoneal Aerosol Chemotherapy, a Palliative Treatment Approach for Patients With Peritoneal Carcinomatosis: Description of Method and Systematic Review of Literature Winkler CS, Sandhu J, Pettke E, Merchea A, Fong Y, Kumara HMCS, Whelan RL

Primary appendiceal mucinous neoplasm: Gynecological manifestations, management, and prognosis Zhang W, Tan C, Xu M, Wu X

Cell-Free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer Pairawan S, Hess KR, Janku F, Sánchez NS, Shaw KRM, Eng C, Damodaran S, Javle M, Kaseb A, Hong DS, Subbiah V, Fu S, Fogelman DR, Raymond VM, Lanman RB, Meric-Bernstam F

Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile? Narasimhan V, Cheung F, Waters P, Peacock O, Warrier S, Lynch C, Michael M, Ramsay R, Heriot A

The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm Najla Aldaoud, Madiha Erashdi, Sohaib AlKhatib, Nour Abdo, Alia Al-Mohtaseb, and Ashley Graboski-Bauer

Risk of appendiceal cancer in patients undergoing appendectomy for appendicitis in the era of increasing nonoperative management Pamela Lu MD, Justin C. McCarty DO, MPH, Adam C. Fields MD, Katherine C. Lee MD, MS, Stuart R. Lipsitz ScD, Joel E. Goldberg MD, MPH, Jennifer Irani MD, Ronald Bleday MD, Nelya Melnitchouk MD, MSc

Total pelvic exenterative surgery in patients with peritoneal metastases from appendiceal neoplasms. A case series of 2 patients Sugarbaker PH

Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei Lei Liang, Wenhai Wang, Nan Zhou, Jun Guo, Yiyan Lu, Hongbin Xu & Shutian Zhan

Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK

Appendiceal mucinous neoplasm mimics ovarian tumors: Challenges for preoperative and intraoperative diagnosis and clinical implication Zhang W, Tan C, Xu M, Wu X

Accelerating the learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using an external mentor model Ansari N, Brown KGM, McBride KE, Steffens D, Koh CE, Young CJ, Solomon MJ, Moran BJ

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB

Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis Pesce S, Belgrano V, Greppi M, Carlomagno S, Squillario M, Barla A, Della Chiesa M, Di Domenico S, Mavilio D, Moretta L, Candiani S, Sivori S, De Cian F, Marcenaro E

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancer Gockel I, Jansen-Winkeln B, Haase L, Niebisch S, Moulla Y, Lyros O, Lordick F, Schierle K, Wittekind C, Thieme R

Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH

Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas Yozu M, Johncilla ME, Srivastava A, Ryan DP, Cusack JC, Doyle L, Setia N, Yang M, Lauwers GY, Odze RD, Misdraji J

Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis Singh B, Fisher OM, Singh G, Lansom J, Bock M, Kozman M, Alzahrani N, Liauw W, Morris DL

Pathological prognostic factors of pseudomyxoma peritonei Yan FC, Lin YL, Zhao HY, Zhou Q, Chang H, Li Y

The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases Najah H, Malgras B, Dohan A, Gronnier C, Eveno C, Pocard M

Pseudomyxoma Peritonei-An Unusual Cause of Ascites: A Case Report Chhabra P, Soni S, Khurana H

Appendiceal cancer masked as inflammatory appendicitis in the elderly, not an uncommon presentation (Surveillance Epidemiology and End Results (SEER)-Medicare Analysis) Siddharthan RV, Byrne RM, Dewey E, Martindale RG, Gilbert EW, Tsikitis VL

Prognostic significance of the presence of epithelial cell clusters in the ascites of patients with pseudomyxoma peritonei Ishida M, Mizumoto A, Yonemura Y, Kashu I, Takemura S, Tsuta K

*Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors Khalili M, Zhou H, Thadi A, Daniels L, Fan Z, Morano WF, Ang J, Goldstein, E, Polyak B, Mapow B, Cheng H, Bowne WB

Robotic-assisted cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) Gabriel E, Elli E, Bagaria S, Wasif N, Grotz T, Stauffer J, Kasi PM, Asbun H

Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms van Eden WJ, Kok NFM, Snaebjornsson P, Jóźwiak K, Woensdregt K, Bottenberg PD, Boot H, Aalbers AGJ

Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States Ellis RJ, Schlick CJR, Yang AD, Barber EL, Bilimoria KY, Merkow RP

Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei Benhaim L, Faron M, Gelli M, Sourrouille I, Honoré C, Delhorme JB, Elias D, Goere D

Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer Baumgartner JM, Marmor R, Hsu A, Veerapong J, Kelly KJ, Lowy AM

Complicated appendiceal diverticulosis versus low grade appendiceal mucinous neoplasms: a major diagnostic dilemma Lowes H, Rowaiye B, Carr NJ, Shepherd NA

Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study Sueda T, Murata K, Takeda T, Kagawa Y, Hasegawa J, Komori T, Noura S, Ikeda K, Tsujie M, Ohue M, Ota H, Ikenaga M, Hata T, Matsuda C, Mizushima T, Yamamoto H, Sekimoto M, Nezu R, Mori M, Doki Y

Correlation of molecular and morphologic features of appendiceal epithelial neoplasms Tsai JH, Yang CY, Yuan RH, Jeng YM

Discordant Diagnostic Terminology and Pathologic Grading of Primary Appendiceal Mucinous Neoplasms Reviewed at a High-Volume Center Choudry HA, Pai RK, Parimi A, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Bartlett DL

Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, Tie J, Akhurst T, Mitchell C, Ramsay R, Heriot A

Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival Solomon D, DeNicola N, Feingold D, Liu PH, Aycart S, Golas BJ, Sarpel U, Labow DM, Magge DR

Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin Munoz-Zuluaga CA, King MC, Ledakis P, Gushchin V, Sittig M, Nieroda C, Zambrano-Vera K, Sardi A

Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies Cascales Campos PA, González-Gil A, Gómez-Ruiz AJ, Gil-Gómez E, Alconchel-Gago F, Navarro-Barrios A, Martínez-García J, Alonso-Romero JL, Nieto A, Barceló-Valcarcel F, Gil-Martínez J

Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM

Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC Munoz-Zuluaga C, King MC, Sardi A, Ledakis P, Sittig M, Nieroda C, MacDonald R, Gushchin V

Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (L-CRS/HIPEC) for Perforated Low-Grade Appendiceal Mucinous Neoplasm (LAMN II) Parkin E, Selvasekar C, Wilson M, Renehan A, O’Dwyer S, Aziz O

Typical carcinoids, goblet cell carcinoids, mixed adenoneuroendocrine carcinomas, neuroendocrine carcinomas and adenocarcinomas of the appendix: a comparative analysis of survival profile and predictors Onyemkpa C, Davis A, McLeod M, Oyasiji T

Spectrum of computed tomography manifestations of appendiceal neoplasms: acute appendicitis and beyond Mercier F, Dagbert F, Pocard M, Goéré D, Quenet F, Wernert R, Dumont F, Brigand C, Passot G, Glehen O; RENAPE Network

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Parkin E, Selvasekar C, Wilson M, Renehan A, O’Dwyer S, Aziz O

Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma Shida D, Kanemitsu Y, Hamaguchi T, Shimada Y

Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei Hotta M, Minamimoto R, Gohda Y, Igari, Yano H

Appendiceal adenocarcinoma—Two unique cases of adenocarcinoma ex‐goblet cell carcinoid Mairead M. Hennessy and Ivan Ivanovski

Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets Park HY, Kwon MJ, Kang HS, Kim YJ, Kim NY, Kim MJ, Min KW, Choi KC, Nam ES, Cho SJ, Park HR, Min SK, Seo J, Choe JY, Lee HK

A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm Sullivan BJ, Bolton N, Sarpel U, Magge D

Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Munoz-Zuluaga C, Sardi A, King MC, Nieroda C, Sittig M, MacDonald R, Gushchin V

Restrictive Intraoperative Fluid Therapy is Associated with Decreased Morbidity and Length of Stay Following Hyperthermic Intraperitoneal Chemoperfusion Hendrix RJ, Damle A, Williams C, Harris A, Spanakis S, Lambert DH, Lambert LA

Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study Votanopoulos KI, Mazzocchi A, Sivakumar H, Forsythe S, Aleman J, Levine EA, Skardal

Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel Ben-Yaacov A, Nizri E, Lahat G, Berger Y, Sadot E, Lavi R, Zippel D, Sebbag G, Avital I, Hoffman A, Gutman M, Halevy A, Schneibaum S, Ben-Ari G, Benchimol D, Klausner J, Nissan A; Israeli Peritoneal Oncology Research Group

Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO Sinukumar S1, Mehta S2, As R3, Damodaran D4, Ray M5, Zaveri S6, Kammar P2, Bhatt A7

Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review Sugarbaker PH

Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Bevacizumab Combined With Oxaliplatin/Capecitabine in Patient With Refractory and Recurrent Mucinous Adenocarcinoma of the Appendix: A Case Report Liu W, Liu L, Wang R, Gong G, Ding X, Yang B, Bao Y, Wang Z, Zhang B, Zhao D, Wu F, Ding Y

A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm Sullivan BJ, Bolton N, Sarpel U, Magge D

Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database Byrne RM, Gilbert EW, Dewey EN, Herzig DO, Lu KC, Billingsley KG, Deveney KE, Tsikitis VL

*Pre- and post-operative antibiotics in conjunction with cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) should be considered for pseudomyxoma peritonei (PMP) treatment Merrell DS, McAvoy TJ, King MC, Sittig M, Millar EV, Nieroda C, Metcalf JL, Blum FC, Testerman TL, Sardi A

Factors Predictive of Outcomes after Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colon and Appendiceal Carcinomatosis: A Single-Institution Experience Graversen M, Detlefsen S, Pfeiffer P, Lundell L, Mortensen MB

Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey Byrne RM, Gilbert EW, Dewey EN, Herzig DO, Lu KC, Billingsley KG, Deveney KE, Tsikitis VL

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei Choudry HA, Pai RK2, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL

Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms Narasimhan V, Pham T, Warrier S, Craig Lynch A, Michael M, Tie J, Ramsay R, Heriot A

Molecular profiling of appendiceal adenocarcinoma and comparison with right-sided and left-sided colorectal cancer Tokunaga R, Xiu J, Johnston C, Goldberg RM, Philip PA, Seeber A, Naseem M, Lo JH, Arai H, Battaglin F, Puccini A, Berger MD, Soni S,Zhang W, Hwang JJ, Shields AF, Marshall JL, Baba H, Korn WM, Lenz HJ

Intraoperative macroscopic tumour consistency is associated with overall survival after cytoreductive surgery and intraperitoneal chemotherapy for appendiceal adenocarcinoma with peritoneal metastases: A retrospective observational study Huang Y, Alzahrani NA, Fisher OM, Chua TC, Kozman MA, Liauw W, Arrowaili A, Valle SJ, Morris DL

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for patients at High-Risk of Peritoneal Metastases Morris MC, Dhar VK, Stevenson MA, Winer LK, Lee TC, Wang J, Ahmad SA, Patel SH, Sussman JJ, Abbott DE

Analysis of Mutation and Loss of Heterozygosity by Whole-Exome Sequencing Yields Insights into Pseudomyxoma Peritonei Pengelly RJ, Rowaiye B, Pickard K, Moran B, Dayal S, Tapper W, Mirnezami A, Cecil T, Mohamed F, Carr N, Ennis S

Pseudomyxoma peritonei of the appendix after ileocecal resection: Expect the unexpected Simsek M, Linn AJ, de Boer NKH

Mutation Profile of High-Grade Appendiceal Mucinous Neoplasm Liao X, Vavinskaya V, Sun K, Hao Y, Li X, Valasek M, Xu R, Polydorides AD, Houldsworth J, Harpaz N

What is a ‘mucocele’ of the appendix and how are these lesions best managed? Beware the wolf in sheep’s clothing Sakata S, Moran BJ

Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases Kyang LS, Alzahrani NA, Valle SJ, Rahman MK, Arrowaili A, Liauw W, Morris DL

Systemic chemotherapy and survival in patients with metastatic low-grade appendiceal mucinous adenocarcinoma Lu P, Fields AC, Meyerhardt JA, Davids JS, Shabat G, Bleday R, Goldberg JE, Nash GM, Melnitchouk N

Improved Survival with Experience: A 10-Year Learning Curve in Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery Leigh NL, Solomon D, Feingold D, Magge DR, Golas BJ, Sarpel U, Labow DM

Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei Sørensen O, Andersen AM, Larsen SG, Giercksky KE, Flatmark K

A single-center clinical analysis of 65 cases of pseudomyxoma peritonei from appendiceal origin in the early stage Ma RQ, Xia A, Zhai XC, Chen F, Xu HB

Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers Shaib WL, Zakka K, Staley C 3rd, Roberts A, Akce M, Wu C, Alese OB, El-Rayes BF

Peritoneal carcinomatosis of unknown primary site may be an undiagnosed appendiceal adenocarcinoma. A case series Sugarbaker PH

Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM

Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC Graf W, Cashin PH, Ghanipour L, Enblad M, Botling J, Terman A, Birgisson H

History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century Francisco J Morera-Ocon and Clara Navarro-Campoy

Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review Stein A, Strong E, Clark Gamblin T, Clarke C, Tsai S, Thomas J, George B, Mogal H

Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix Fields AC, Lu P, Enzinger A, Goldberg J, Irani J, Bleday R, Nash G, Melnitchouk N

Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Zambrano-Vera, Sardi, Munoz-Zuluaga, Studeman, Nieroda, Sittig, King, Sipok, Gushchin

The prognostic relevance of histologic subtype in appendiceal adenocarcinoma Legué LM, van Erning FN, Creemers GJ, de Hingh IHJT, Lemmens VEPP, Huysentruyt CJ

Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis Mikael L. Soucisse, Winston Liauw, Gabrielle Hicks, and David L. Morris

Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin Moaven O, Votanopoulos KI, Shen P, Mansfield P, Bartlett DL, Russell G, McQuellon R, Stewart JH, Levine EA

Impact of Referral Center Pathology Review on Diagnosis and Management of Patients With Appendiceal Neoplasms Jedrzkiewicz J, Tateishi Y, Kirsch R, Conner J, Bischof D, McCart A, Riddell R, Pollett A, Taylor EL, Govindarajan A

Early recurrence in peritoneal metastasis of appendiceal neoplasm: Survival and prognostic factors Kyang LS, Alzahrani N, Alshahrani M, Rahman MK, Liauw W, Morris D

Immunophenotypic Comparison of Neoplasms of the Appendix, Right Colon, and Left Colon in Search of a Site-Specific Phenotypic Signature Mesa H, Manivel JC, Larson WS, Dachel SK, Reinink AR, Jessurun J

 

Glycomic Profiling Highlights Increased Fucosylation in Pseudomyxoma Peritonei Lilli Saarinen, Pirjo Nummela, Hannele Leinonen, Annamari Heiskanen, Alexandra Thiel, Caj Haglund, Anna Lepistö, Tero Satomaa, Sampsa Hautaniemi, and Ari Ristimäki

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy Levine Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M

Pseudomyxoma Peritonei: Presentation of Two Cases and Challenging Issues in the Literature Pantiora EV, Massaras D, Koutalas J, Melemeni A, Fragulidis GP

Signet ring cell features with peritoneal carcinomatosis in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy are associated with poor overall survival Daniel S, DeNicola N, Feingold D, Liu PH, Aycart S, Golas BJ, Sarpel U, Labow DM, Magge DR. GP

Low-grade Appendiceal Mucinous Neoplasm Presenting as Adnexal Mass: A Case Report Pantiora EV, Massaras D, Koutalas J, Bagiasta A, Kontis EA, Fragulidis GP

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B, Bartlett D, Smith L

An analysis of the morbidity associated with abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) Parikh R, Shah S, Dhurandhar V, Alzahrani N, Fisher OM, Arrowaili A, Liauw W, Morris D

Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei Beane JD, Wilson GC, Sutton JM, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Holtzman MP, Zureikat AJ, Ahrendt SA, Zeh HJ, Bartlett DL, Choudry HA

Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei Legué LM, Creemers GJ, de Hingh IHJT, Lemmens VEPP, Huysentruyt CJ

Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapy Singh B, Singh G, Alzahrani N, Arrowaili A, Morris DL

Mucinous appendiceal neoplasms: classification, imaging, and HIPEC Bartlett DJ, Thacker PG Jr, Grotz TE, Graham RP, Fletcher JG, VanBuren WM, Iyer VR, Fidler JL, Menias CO, Wasif N, Sheedy SP

Recurrence of pseudomyxoma peritonei with liver and splenic metastases: about a case and literature review Azzakhmam M, Zouaidia F, Jahid A, Znati K, Bernoussi Z, Mahassini N

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris D

ASO Author Reflections: Proposal of a New Preoperative Score to Predict Resectability in Pseudomyxoma Peritonei Dohan A, Bouquot M, Rousset P, Eveno C

Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience Feferman Y, Solomon D, Bhagwandin S, Kim J, Aycart SN, Feingold D, Sarpel U, Labow DM

Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Feferman Y, Solomon D, Bhagwandin S, Kim J, Aycart SN, Feingold D, Sarpel U, Labow DM

Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Gani F, Conca-Cheng AM, Nettles B, Ahuja N, Johnston FM

Predictors of Readmission After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Paredes AZ, Abdel-Misih S, Schmidt C, Dillhoff ME, Pawlik TM, Cloyd JM

Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Munoz-Zuluaga C, Sardi A, King MC, Nieroda C, Sittig M, MacDonald R, Gushchin V

Liver scalloping: Pseudomyxoma peritonei liver compression Allart K, Sabbagh C, Regimbeau JM

Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy Tzivanakis A, Dayal SP, Arnold SJ, Mohamed F, Cecil TD, Venkatasubramaniam AK, Moran BJ

Cellularity in low-grade Pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Horvath P, Yurttas C, Birk P, Struller F, Königsrainer A

Non-home Discharge and Prolonged Length of Stay After Cytoreductive Surgery and HIPEC Burguete D, Mokdad AA, Augustine MM, Minter R, Mansour JC, Choti MA, Polanco PM

Clinicopathological Criteria Defining Mucinous Appendiceal Tumors from 2476 Appendectomies: a Single-Center Retrospective Study El-Esawy BH, Abd El Hafez A, Abdelaziz AM

Sclerosing encapsulating peritonitis as a potential complication of cytoreductive surgery and HIPEC: Clinical features and results of treatment in 4 patients Liberale G, Sugarbaker PH

Outcomes of Low-Grade Appendiceal Mucinous Neoplasms with Remote Acellular Mucinous Peritoneal Deposits Roxburgh CS, Fenig YM, Cercek A, Shia J, Rassam RM, Paty PB, Nash GM

Low Grade Appendiceal Mucinous Neoplasm Diagnosed During Exploratory Laparoscopy for a Presumed Pelvic Mass Hosier H, Ratner E, Menderes G

Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study Votanopoulos KI, Mazzocchi A, Sivakumar H, Forsythe S, Aleman J, Levine EA, Skardal A

Short-term complications in elderly patients undergoing CRS and HIPEC: A single center’s initial experience Oemrawsingh A, de Boer NL, Brandt-Kerkhof ARM, Verhoef C, Burger JWA, Madsen EVE

Laparoscopic ileocecal resection can be applied for appendiceal cancer with an ileal fistula: A case report Mukohyama J, Sumi Y, Kanemitsu K, Hasegawa H, Yamamoto M, Kanaji S, Matsuda Y, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y

Gastrointestinal: Successful endoscopic submucosal dissection assisted with endoloop for early appendiceal cancer that had everted into the cecal lumen Tashima T, Nonaka K, Ryozawa S, Tanisaka

Gastrointestinal: Successful endoscopic submucosal dissection assisted with endoloop for early appendiceal cancer that had everted into the cecal lumen Tashima T, Nonaka K, Ryozawa S, Tanisaka Y

Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL

Knowledge, attitudes and practice of surgeons regarding nutritional support in CRS and HIPEC patients: Are we missing something? Naffouje SA, De La Cruz K, Berard D, Guy S, Salti GI

Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy Singh B, Singh G, Pourgholami M, Alzahrani N, Morris DL

Long-term Survival and Propensity Score Matched Outcomes of Bilateral vs. Unilateral Diaphragm Interventions in Cytoreductive Surgery plus Intra-peritoneal Chemotherapy Singh B, Singh G, Pourgholami M, Alzahrani N, Morris DL

Coexistence of low-grade mucinous neoplasm and carcinoid (collision tumor) within multiple appendiceal diverticula: A case report Ekinci N, Gün E, Avcı A, Er A

Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Peritoneal Metastases Sommariva A, Tonello M, Cona C, Pilati P, Rossi CR

Approach to pseudomyxoma peritonei Rizvi SA, Syed W, Shergill R

The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Tumors and Colorectal Adenocarcinomas Kuncewitch M, Levine EA, Shen P, Votanopoulos KI

Appendiceal Neoplasms Hatch QM, Gilbert EW

Autopsy of an expert consensus: End of hyperthermic intraperitoneal chemotherapy in colorectal carcinomatosis Evrard S

Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels Takahashi J, Tsujinaka S, Kakizawa N, Takayama N, Machida E, Iseya K, Hasegawa F, Kikugawa R, Miyakura Y, Suzuki K, Rikiyama T

Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis Guerrero W, Munene G, Dickson PV, Stiles ZE, Mays J, Davidoff AM, Glazer ES, Shibata D, Deneve JL

Unusual case of intraluminal cecal recurrence of a low grade appendiceal mucinous neoplasm (LAMN)-Case report and brief literature review Givalos N, Manolidis G, Kochylas N, Vrachni V, Tsakona S, Eftychiadis C, Vrachnos P

Management and prognosis of low-grade appendiceal mucinous neoplasms: A clinicopathologic analysis of 50 cases Li X, Zhou J, Dong M, Yang L

The Problem of Appendiceal Carcinoids Galanopoulos M, Toumpanakis C

Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC Nizri E, Kusamura S, Fallabrino G, Guaglio M, Baratti D, Deraco M

Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: comparison of an experimental duplex drug to standard drug regimens in vitro Weinreich J, Struller F, Sautkin I, Giuashvili S, Reymond M, Königsrainer A, Schott TC

Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei Govaerts K, Chandrakumaran K, Carr NJ, Cecil TD, Dayal S, Mohamed F, Thrower A, Moran BJ

A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis Arjona-Sanchez A, Esquivel J, Glehen O, Passot G, Turaga KK, Labow D, Rufian-Peña S, Morales R, van der Speeten K

Appendicular schwannoma presenting as vague abdominal pain Alshamrani AM, Sairafi RA, Alzahrani AM, Abdel-Raheem M

Adenocarcinoma Ex-Goblet Cell: a Retrospective Experience Das S, Shi C, Du L, Idrees K, Berlin J.BJ

Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival Baumgartner JM, Raymond VM, Lanman RB, Tran L, Kelly KJ, Lowy AM, Kurzrock R

Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival Baumgartner JM, Raymond VM, Lanman RB, Tran L, Kelly KJ, Lowy AM, Kurzrock R

Psoas/iliacus muscle invasion from mucinous appendiceal neoplasm. Radiologic appearance and outcome of treatment in 3 patients Sugarbaker PH

Peritoneal Metastases from Appendiceal Cancer Votanopoulos KI, Shen P, Skardal A, Levine EA

Patient Selection for Cytoreductive Surgery Grotz TE, Fournier KF, Mansfield PF

Feasibility of hand-assisted laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy Salti GI, Naffouje SA

Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme Fish R2, Renehan AG, Punnett G, Aziz O, Fulford P, Selvasekar C, Wilson M, Halstead R, O’Dwyer ST

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix Tsang ES, McConnell YJ, Schaeffer DF, Lee L, Yin Y, Zerhouni , Schaff K, Speers C, Kennecke HF

Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis Panuganti B, Chang ES, Helm CW, Schwartz T, Hsueh EC, Piao J, Lai J6, Veerapong J

SATB2 Shows Different Profiles Between Appendiceal Adenocarcinomas Ex Goblet Cell Carcinoids and Appendiceal/Colorectal Conventional Adenocarcinomas: An Immunohistochemical Study With Comparison to CDX2 Yang C, Sun L, Zhang L, Zhou L, Niu D, Cao W, Li Z, Huang X, Kang Q, Jia L, Platik M, Liu X, Lai J, Cao D

Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis Graversen M, Detlefsen S, Bjerregaard JK, Fristrup CW, Pfeiffer P, Mortensen MB

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results ofa multicenter international study Mehta S, Schwarz L, Spiliotis J, Hsieh MC, Akaishi EH, Goere D, Sugarbaker PH, Baratti D, Quenet F, Bartlett DL, Villeneuve L, Kepenekian V; PSOGI and BIG-RENAPE Working Groups

Peritoneal Metastases from Gastrointestinal Cancer Paul H. Sugarbaker

Fistula Formation Secondary to Mucinous Appendiceal Adenocarcinoma may be Related to a Favorable Prognosis: A Case Report and Literature Review Yokode M, Ikeda E, Matsui Y, Iwamura S, Mikami S, Kobayashi H, Imai Y, Kaihara S, Yamashita Y

Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Tan GHC, Chia CS, Tan SH, Soo KC, Teo MCC

Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Tan GHC, Chia CS, Tan SH, Soo KC, Teo MCC

Ureteral Obstruction Secondary to an Appendiceal Mucocele: A Case Report and Literature Review Djuimo M, Feldman LS, Andonian S

Clinical significance of appendiceal diverticulum: a significant marker for appendiceal neoplasia in Australian patients Chan DL, Lim C, Bakhtiar A, Khoury M, Smigelski M, Yeh D, Ravindran P

Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix: 2018 Update Zhang Y, Zulfiqar M, Bluth MH, Bhalla A, Beydoun R

Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms Mao W, Lyu Y, Pu N, Li J, Xin B, Chen W, Jin D, Lou W, Xu X

Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma Aziz O, Jaradat I, Chakrabarty B, Selvasekar CR, Fulford PE, Saunders MP, Renehan AG, Wilson MS, O’Dwyer ST

Endoscopic diagnosis of a goblet cell carcinoid tumour of the appendix Falk V, Ballantyne M, Zepeda-Gómez S, Kohansal-Vajargah A

Endoscopic diagnosis of a goblet cell carcinoid tumour of the appendix Falk V, Ballantyne M, Zepeda-Gómez S, Kohansal-Vajargah A

Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons Yoo HJ, Hong JJ, Ko YB, Lee M, Kim Y, Han HY, Song YJ, Lim MC, Park SY

Appendiceal diverticulosis: a harbinger of underlying primary appendiceal adenocarcinoma? Ng JL, Wong SL, Mathew R

Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy Guerrero WL, Munene G, Dickson PV, Darby D, Davidoff AM, Martin MG, Glazer ES, Shibata D, Deneve JL

Single-center analysis of appendiceal neoplasms Tajima T, Tajiri T, Mukai M, Sugiyama T, Hasegawa S, Yamamoto S, Sadahiro S, Shimada H, Makuuchi H

Appendiceal carcinoma associated with microsatellite instability Morales-Miranda A, Rosado ID, Núñez CC, Montero FC

Sister Mary Joseph Nodule as a Cutaneous Manifestation of Metastatic Appendiceal Adenocarcinoma: Case Report and Literature Review Girijala RL, Riahi RR, Cohen PR

Impact of Synchronous Liver Resection on the Perioperative Outcomes of Patients Undergoing CRS-HIPEC Cloyd JM, Abdel-Misih S, Hays J, Dillhoff ME, Pawlik TM, Schmidt C

The hepatic bridge Sugarbaker PH

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients Weiss A, Ward EP, Baumgartner JM, Lowy AM, Kelly KJ

Goblet cell carcinoid of the appendix: Case report of a high grade tumor in a 20-year-old Barghi A, Grabbe J, Ghosh A

Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study Ravn S, Thaysen HV, Harsløf S, Sørensen MM, Iversen LH

Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy for Management of Peritoneal Carcinomatosis Nikeghbalian S, Nikoupour H, Dehghani M, Karami MY, Hemati R

Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J

Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J

Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification Bhatt A, Mishra S, Prabhu R, Ramaswamy V, George A, Bhandare S, Shah M, Mehta S

Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis Su SS, Zheng GQ, Yin WJ, Liang YF, Liu YY, Song H, Sun NN, Yang YX

Pseudomyxoma peritonei in a pediatric patient: A case report and literature review Fernandes ACO, Rocha GRMD, Oliveira AD, Guimarães MD, Carvalho SC, Chojniak

Genomic Profile of Appendiceal Goblet Cell Carcinoid Is Distinct Compared to Appendiceal Neuroendocrine Tumor and Conventional Adenocarcinoma Wen KW, Grenert JP, Joseph NM, Shafizadeh N, Huang A, Hosseini M, Kakar S

Impact of Concomitant Urologic Intervention on Clinical Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Saxena A, Liauw W, Virk SA, Morris DL

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: risk factors for morbidity and postoperative outcome Robella M, Vaira M, Cinquegrana A, Borsano A, DE Simone M

Clinicopathological Features and Management of Appendiceal Mucoceles: A Systematic Review Morano WF, Gleeson EM, Sullivan SH, Padmanaban V, Mapow BL, Shewokis PA, Esquivel J, Bowne WB

Histologic and Outcome Study Supports Reclassifying Appendiceal Goblet Cell Carcinoids as Goblet Cell Adenocarcinomas, and Grading and Staging Similarly to Colonic Adenocarcinomas Yozu M, Johncilla ME, Srivastava A, Ryan DP, Cusack JC5, Doyle L, Setia N, Yang M, Lauwers GY, Odze RD, Misdraji J

What the radiologist should know about postoperative MDCT evaluation of a patient treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy Durot C, Rousset P, Thivolet A, Passot G, Deguelte S, Dohan A, Glehen O, Hoeffel C

Risk factors for appendiceal and colorectal peritoneal metastases Enblad M, Graf W, Birgisson H

The value of grading dysplasia in appendiceal mucinous neoplasm (AMN) in the absence of pseudomyxoma peritonei Singhal S, Giner-Segura F, Barnes TG, Hompes R, Guy R, Wang LM

Clinicopathologic characteristics of pseudomyxoma peritonei] Zhou Q, Shi F, Zhao HY, Li Y, Song QK

Clinicopathologic characteristics of pseudomyxoma peritonei Zhou Q, Shi F, Zhao HY, Li Y, Song QK

Pseudomyxoma peritonei: A case report and review of the literature Gómez Rivas J, Alonso-Dorrego JM, Carrión DM, Vega Robalino M, González-Peramato P

MR Imaging of Secondary Massive Ovarian Edema Caused by Ovarian Metastasis from Appendiceal Adenocarcinoma Tanaka YO, Takazawa Y, Matsuura M, Omatsu K, Takeshima N, Matsueda K

Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy of appendiceal and colorectal cancer origin Bignell MB, Mehta AM, Alves S, Chandrakumaran K, Dayal SP, Mohamed F, Cecil TD, Moran BJ

A Case of Laparoscopy Assisted Ileocecal Resection for Large Appendiceal Mucinous Adenocarcinoma Hashimoto M, Murata K, Kagawa Y, Naito A, Kawai K, Sakamoto T, Murakami K, Katsura Y, Omura A, Masuzawa T, Takeno A, Yoshimura M, Takeda Y, Kato T, Tamura S

Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies Dreznik Y, Hoffman A, Hamburger T, Ben-Yaacov A, Dux Y, Jacoby H, Berger Y, Nissan A, Gutman M

Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment Sugarbaker PH

Goblet cell carcinoid of the appendix – An interobserver variability study using two proposed classification systems Maedler C, Arnason T, Dorreen A, Sapp H, Castonguay M, Murphy J, Selegean S, Huang WY

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin Delhorme JB, Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C; French National Network of Peritoneal Surface Malignancies (RENAPE)

A Case of Appendiceal Mucinous Adenocarcinoma Detected with a Bladder Tumor Tsutsumi S, Murata A, Yamauchi Y, Okano K, Yokoyama H, Kimura A, Ishizawa Y, Umehara M, Kato M, Hashimoto N, Umehara Y, Nishikawa S, Takahashi K, Morita T

Palliative Management of Peritoneal Metastases Dreznik Lambert LA, Wiseman J

An uncommon cecal bulge caused by a large appendiceal mucinous neoplasm Ma MX, Kong J, Hillery S, Cheah K

Correction to: Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series Guaglio M, Sinukumar S, Kusamura S, Milione M, Pietrantonio F, Battaglia L, Guadagni S, Baratti D, Deraco M

Unexpected findings in the routine histopathological examinations of appendectomy specimens A retrospective analysis of 1,970 patients Dincel O, Goksu M, Turk BA, Pehlivanoglu B, Isler S

A Multi-Center Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors Levine EA, Votanopoulos KI, Shen P, Russell G, Fenstermaker J, Mansfield P, Bartlett D, Stewart JH

Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix Jesinghaus M, Konukiewitz B, Foersch S, Stenzinger A, Steiger K, Muckenhuber A, Groß C, Mollenhauer M, Roth W, Detlefsen S, Weichert W, Klöppel G, Pfarr N, Schlitter AM

Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study Stearns AT, Malcomson L, Punnett G, Abudeeb H, Aziz O, Selvasekar CR, Fulford PE, Wilson MS, Renehan AG, O’Dwyer ST

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Elderly Patients: Complete Cytoreduction Is Feasible and Crucial for Improved Survival Despite High Carcinomatosis Index Naffouje SA, Salti GI

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: A single-center experience Azzam AZ, Alyahya ZA, Wusaibie AAA, Amin TM

Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin Kitai T, Yamanaka K

Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Kelly KJ, Cajas L, Baumgartner JM, Lowy AM

Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma Shida D, Kanemitsu Y, Hamaguchi T, Shimada Y

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified? López-López V, Cascales-Campos PA, Gil E, Arevalo J, Gonzalez A, Gil J, Muñoz-Casares FC, Melero JT, Barrios P, Morales R, Ramos I, Ortega G, Camps B,González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Parrilla P

Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Wong EYT, Tan GHC, Chia CSL, Kumar M, Soo KC, Teo MCC

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF

Cancers of the appendix. Case report and literatures review Izzo P, De Santis A, Pugliese F, Valabrega S, Izzo L

Adenocarcinoma Ex-Goblet Cell Carcinoid of the Appendix With Metastatic Peritoneal Spread to Meckel’s Diverticulum and Endometriosis Lowenthal BM, Lin GY, Tipps AMP, Hosseini M

Synchronous small intestinal and appendiceal neuroendocrine tumours: a rare case Lendzion R, Phan-Thien KC

Single centre guidelines for radiological follow-up based on 775 patients treated by cytoreductive surgery and HIPEC for appendiceal pseudomyxoma peritonei Govaerts K, Chandrakumaran K, Carr NJ, Cecil TD, Dayal S, Mohamed F, Thrower A, Moran BJ

Fistula Formation Secondary to Mucinous Appendiceal Adenocarcinoma May Be Related to a Favorable Prognosis: A Case Report and Literature Review Yokode M, Ikeda E, Matsui Y, Iwamura S, Mikami S, Kobayashi H, Imai Y, Kaihara S, Yamashita Y

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy F. Mercier F. Dagbert M. Pocard D. Goéré F. Quenet R. Wernert F. Dumont C. Brigand G. Passot O. Glehen the RENAPE Network

Expert Commentary on Appendiceal Neoplasms Konstantinos I. Votanopoulos

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) through a single port: alternative delivery for the control of peritoneal metastases Seitenfus R, Kalil AN, de-Barros ED, Fedrizzi G

Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases Saxena A, Valle SJ, Liauw W, Morris DL

Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score Bouquot M, Dohan A, Gayat E, Barat M, Glehen O, Pocard M, Rousset P, Eveno C

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC Schneider MA, Eshmuminov D, Lehmann K

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center Yu HH, Yonemura Y, Hsieh MC, Mizumoto A, Wakama S, Lu CY

Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC) Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI

SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases Schmoeckel E, Kirchner T, Mayr D

A case report of a giant appendiceal mucocele and literature review Motsumi MJ, Motlaleselelo P, Ayane G, Sesay SO, Valdes JR

Clinical Surveillance After Macroscopically Complete Surgery for Low-Grade Appendiceal Mucinous Neoplasms (LAMN) with or Without Limited Peritoneal Spread: Long-Term Results in a Prospective Series Guaglio M, Sinukumar S, Kusamura S, Millione M, Pietrantonio F, Battaglia L, Guadagni S, Baratti D, Deraco M

Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC Reghunathan M, Kelly KJ, Valasek MA, Lowy AM, Baumgartner JM

Core Body Temperature but Not Intraabdominal Pressure Predicts Postoperative Complications Following Closed-System Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Administration Goldenshluger M, Zippel D, Ben-Yaacov A, Dux J, Yalon T, Zendel A, Rayman S, Mor E, Berkenstadt H, Fogel-Grinvald H, Ventorrero M, Nissan A

Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis Pallas N, Karamveri C, Kyziridis D, Hristakis C, Kyriakopoulos V, Kalakonas A, Vaikos D, Tentes AK

PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries Votanopoulos KI, Bartlett D, Moran B, Haroon CM, Russell G, Pingpank JF, Ramalingam L, Kandiah C, Chouliaras K, Shen P, Levine EA

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation Ang C, Stollman A, Zhu H, Sarpel U, Scarborough B, Sahni G, Millis SZ

Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Morris RS, Gani F, Hammad AY, Peltier W, Gamblin TC, Turaga KK, Johnston FM

Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: A preliminary five-year experience Bhatt A, Sheshadri D, Chandan G, Ramaswamy V, Pandey J, Bhorkar N, Agrawal D, Mehta S

Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter? Gahagan JV, Whealon MD, Phelan MJ, Mills S, Pigazzi A, Stamos MJ, Nguyen NT, Carmichael JC

Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI) Goéré D, Passot G, Gelli M, Levine EA, Bartlett DL, Sugarbaker PH, Glehen O

*Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei Dilly AK, Honick BD, Lee YJ, Guo ZS, Zeh HJ, Bartlett DL, Choudry HA

Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis Sánchez-García S, Padilla-Valverde D, Villarejo-Campos P, García-Santos EP, Martín-Fernández J

Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy McMullen JRW, Selleck M, Wall NR, Senthil M

Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Eng OS, Dumitra S, O’Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B

CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study Kozman MA, Fisher OM, Rebolledo BJ, Valle SJ, Alzahrani N, Liauw W, Morris DL

Low-grade appendiceal mucinous neoplasm and endometriosis of the appendix Klingbeil KD, Azab B, Moller MG

The Comprehensive Complication Index: a New Measure of the Burden of Complications After Hyperthermic Intraperitoneal Chemotherapy Dumitra S, O’Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Lee B

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosisfrom Gastric Cancer: Its Beneficial Effects on Reduction and Exact Evaluation of the Peritoneal Cancer Index Takeshita K, Liu Y, Ishibashi H, Yonemura Y

Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination Huang Y, Alzahrani NA, Liauw W, Soudy H, Alzahrani AM, Morris DL

Laparoscopy as a useful selection tool for patients with prior surgery and peritoneal metastases suitable for multimodality treatment strategies von Breitenbuch P, Boerner T, Jeiter T, Piso P, Schlitt HJ

Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis Widmann B, Warschkow R, Schmied BM, Marti L, Steffen T

Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study Madsen AH, Ladekarl M, Villadsen GE, Grønbæk H, Sørensen MM, Stribolt K, Verwaal VJ, Iversen LH

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of pseudomyxoma peritonei: A single-center experience Azzam AZ, Alyahya ZA, Wusaibie AAA, Amin TM

Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin Kitai T, Yamanaka K

Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Baratti D, Kusamura S, Milione M, Bruno F, Guaglio M, Deraco M

Expert Commentary on Appendiceal Neoplasms Konstantinos I. Votanopoulos

Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review Kitai T, Yamanaka K

Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL

The pre-operative neutrophil-lymphocyte ratio predicts overall and disease-free survival following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with pseudomxyoma peritonei of appendiceal origin Rangarajan K, Chandrakumaran K, Dayal S, Mohamed F, Moran BJ, Cecil TD

An Update on the Diagnosis, Grading, and Staging of Appendiceal Mucinous Neoplasms Valasek MA, Pai RK

Grading and Staging Mucinous Neoplasms of the Appendix: A Case Series and Review of the Literature Umetsu SE, Shafizadeh N, Kakar S

Outcome of decompression using a transnasal ileus tube in malignant adhesive bowel obstruction: A retrospective study Han XJ, Zhao F, Su HY, Xu K

Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Mehta A, Mittal R, Chandrakumaran K, Carr N, Dayal S, Mohamed F, Moran B, Cecil T

Conflicting Data on the Incidence of Leukopenia and Neutropenia After Heated Intraperitoneal Chemotherapy with Mitomycin C Feferman Y, Bhagwandin S, Kim J, Aycart SN, Feingold D, Labow DM, Sarpel U

Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T

Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion Pakraftar S, Ramalingam L, Shuai Y, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA

Antimicrobial Properties of Perfusate Fluid After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CS-HIPEC) with Mitomycin C Lange KN, McKay D, Gentry BG, Franko J

Early postoperative intraperitoneal chemotherapy is associated with survival benefit for appendiceal adenocarcinoma with peritoneal dissemination Huang Y, Alzahrani NA, Liauw W, Soudy H, Alzahrani AM, Morris DL

A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy procedures in Brazil: pseudomyxoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma Batista TP, Sarmento BJQ, Loureiro JF, Petruzziello A, Lopes A, Santos CC, Quadros CA, Akaishi EH, Cordeiro EZ, Coimbra FJF, Laporte GA, Castro LS, Batista RMSS, Aguiar S Júnior, Costa WL Júnior, Ferreira FO; Comitê de Neoplasias Peritoneais e Quimioterapia Intraperitoneal Hipertérmica da Sociedade Brasileira de Cirurgia Oncológica

CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study KozmanMA, Fisher OM, Rebolledo BJ, Valle SJ, Alzahrani N, Liauw W, Morris DL

Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF

Suitability of the AUC ratio as an indicator of the pharmacokinetic advantage in HIPEC Mas-Fuster MI, Ramon-Lopez A, Lacueva J, Más-Serrano P, Nalda-Molina R

Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ

Risk of Ovarian Involvement in Advanced Colorectal or Appendiceal Tumors Involving the Peritoneum Mehta AM, Bignell MB, Alves S, Dayal SP, Mohamed F, Cecil TD, Moran BJ

Ultrasound characteristics of ovarian metastases from low-grade appendiceal mucinous neoplasms Moro F, Pozzati F, Mascilini F, Magoga G, Pasciuto T, Zannoni G, Scambia G, Testa AC

Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy Eng OS, Dumitra S, O’Leary M, Raoof M, Wakabayashi M, Dellinger TH, Han ES, Lee SJ, Paz IB, Lee B

A Study of Appendiceal Crypt Cell Adenocarcinoma (So-Called Goblet Cell Carcinoid and Its Related Adenocarcinoma) Nonaka D, Papaxoinis G, Lamarca A, Fulford P, Valle J, Chakrabarty B

Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors Raoof M, Dumitra S, O’Leary MP, Singh G, Fong Y, Lee B

Repeat cytoreductive surgery with or without perioperative intraperitoneal chemotherapy for peritoneal surface malignancy Huang Y, Alzahrani NA, Chua TC,Liauw W, Morris DL

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified? López-López V, Cascales-Campos PA, Gil E, Arevalo J, Gonzalez A, Gil J, Muñoz-Casares FC, Melero JT, Barrios P, Morales R, Ramos I, Ortega G, Camps B, González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Parrilla P

Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC Spiliotis J, Kopanakis N, Efstathiou E, Vassiliadou D, Argiriou O, Rogdakis A, Valavanis C

Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Sommariva A, Evangelista L, Pintacuda G, Cervino AR, Ramondo G, Rossi CR

“PAUSE”: a method for communicating radiological extent of peritoneal malignancy Chandramohan A, Thrower A, Smith SA, Shah N, Moran B

Reconstruction after ureteral resection during HIPEC surgery: Re-implantation with uretero-neocystostomy seems safer than end-to-end anastomosis Pinar U, Tremblay JF, Passot G, Dazza M, Glehen O, Tuech JJ, Pocard M; BIG-RENAPE working group

Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer Fleischmann I, Warschkow R, Beutner U, Marti L, Schmied BM, Steffen T

Short-term outcomes following cytoreductive surgery and heated intra-peritoneal chemotherapy at Waikato Ly NJ, Wu L, Dalen RV, Lolohea S

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF

Does having a gastrectomy delay time to feeding and prolong hospital stay in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Shannon NB, Tan GHC, Chia CS, Soo KC, Teo MC

* Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies Kuracha MR, Thomas P, Loggie BW, Govindarajan V

Predictive value of Peritoneal Cancer Index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single center experience Brandl A, Weiss S, von Winterfeld M, Krannich A, Feist M, Pratschke J, Raue W, Rau B1

Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit Shiralkar SP, Kerr P, Scott J, Sivalingam P

* Predicting appendiceal tumors among patients with appendicitis Loftus TJ1, Raymond SL, Sarosi GA Jr, Croft CA, Smith RS, Efron PA, Moore FA, Brakenridge SC, Mohr AM, Jordan JR

Appendiceal Mucinous Neoplasms: Diagnosis and Management Shaib WL, Assi R, Shamseddine A, Alese OB, Staley C 3rd, Memis B, Adsay V, Bekaii-Saab T, El-Rayes BF

Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan Hsieh MC1, Lu CY, Chang WW, Wu SY, Hsiao PK, Liu TJ

Mucinous appendiceal neoplasms: Incidence, diagnosis and surgical treatment Nutu OA, Marcacuzco Quinto AA, Manrique Municio A, Justo Alonso I, Calvo Pulido J, García-Conde M, Cambra Molero F, Jiménez Romero LC

Limited, local, extracolonic spread of mucinous appendiceal adenocarcinoma after perforation with formation of a malignant appendix-to-sigmoid fistula: Case report and literature review Hakim S1, Amin M1, Cappell MS1

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea Park EJ1, Baik SH, Hur H, Min BS, Kang J, Han YD, Cho MS, Lee KY, Kim NK

Factors associated with thromboembolic events following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Rottenstreich A, Kalish Y, Kleinstern G, Yaacov AB, Dux J, Nissan A

Rare malignant tumors of the appendix: surgical treatment of liver metastases case reports Fichtl J, Vodička J, Třeška V, Skalický T, Tupý R, Šmíd D

Gastric perforation following cytoreductive surgery and perioperative intraperitoneal chemotherapy: a case series of six Kyang LS, Alzahrani NA, Zhao J, Morris DL

Platinum agents and mitomycin C specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Tan GHC, Shannon NB, Chia CS, Soo KC, Teo MCC

Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms Tan GHC, Shamji T, Mehta A, Chandrakumaran K, Dayal S, Mohamed F, Carr NJ, Rowaiye B, Cecil T, Moran BJ

Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Konstantinidis IT, Levine EA, Chouliaras K, Russell G, Shen P, Votanopoulos KI

Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care Valasek MA1, Thung I, Gollapalle E, Hodkoff AA, Kelly KJ, Baumgartner JM, Vavinskaya V, Lin GY, Tipps AP, Hosseini MV, Lowy AM

Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery Dohan A, Barral M, Eveno C, Lo Dico R , Kaci R3, Pasteur-Rousseau A, Soyer P, Pocard M, Bonnin P

Adenocarcinoma of the Appendix Presenting as a Palpable Right Thigh Mass Handler M, Anand N, Wei L, Snieckus P

Survival after resection of appendiceal carcinoma by hemicolectomy and less radical than hemicolectomy: A population-based propensity score matched analysis Elias H, Galata C, Warschkow R, Schmied BM, Steffen T, Post S, Marti L

Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases Saxena A, Valle SJ, Liauw W, Morris DL

Appendiceal Goblet Cell Carcinoid: Common Errors in Staging and Clinical Interpretation with a Proposal for an Improved Terminology Wen KW, Hale G, Shafizadeh N, Hosseini M, Huang A, Kakar S

Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases Morera Ocón FJ, Camps Vilata B, Muñoz Forner E, Navarro Campoy C, Gallego Plazas J, Navarro Fos S

Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma Lemoine L, Sugarbaker P, Van der Speeten K

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea Park EJ, Baik SH, Hur H, Min BS, Kang J, Han YD, Cho MS, Lee KY, Kim NK

Pseudomyxoma peritonei: natural history and treatment Mittal R, Chandramohan A, Moran B

Registries on peritoneal surface malignancies throughout the world, their use and their options Verwaal VJ, Rau B, Jamali F, Gilly FN, de Hingh I, Takala H, Syk I, Pelz J, Mulsow J, van der Speeten K, Shigeki K, Iversen LH, Mohamed F1, Glehen O, Younan R, Yarema R, Gonzalez-Moreno S, O’Dwyer S, Yonemura Y, Sugarbaker P

Platinum agents and mitomycin C specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Tan GHC, Shannon NB, Chia CS, Soo KC, Teo MCC

Kocher maneuver to facilitate cytoreduction within the foramen of Winslow Han SS, Sugarbaker PH

Computed Tomography Follow-Up Assessment of Patients with Low-Grade Appendiceal Mucinous Neoplasms: Evaluation of Risk for Pseudomyxoma Peritonei Tiselius C, Kindler C, Shetye J, Letocha H, Smedh K

Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery Uemura M, Qiao W, Fournier K, Morris J, Mansfield P, Eng C, Royal RE, Wolff RA, Raghav K, Mann GN, Overman MJ

Adenocarcinoma Ex-Goblet Cell Carcinoid of the Appendix With Metastatic Peritoneal Spread to Meckel’s Diverticulum and Endometriosis Lowenthal BM, Lin GY, Tipps AMP, Hosseini M

Adenocarcinoma as a Cause of Acute Appendicits Sugarbaker PH

Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritonei Lilli Saarinen, Pirjo Nummela, Alexandra Thiel, Rainer Lehtonen, Petrus Järvinen, Heikki Järvinen, Lauri A. Aaltonen, Anna Lepistö, Sampsa Hautaniemi, Ari Ristimäk

Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hübner M

Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience Gupta N, Asif S, Gandhi J, Rajpurohit S, Singh S

A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Ihemelandu C, Fernandez S, Sugarbaker PH

A Prognostic Model for Evaluation of the peritoneal carcinomatosis index with CT and MRI Dohan A, Hoeffel C, Soyer P, Jannot AS, Valette PJ, Thivolet A, Passot G, Glehen O, Rousset P

Dual Immunostain With SATB2 and CK20 Differentiates Appendiceal Mucinous Neoplasms From Ovarian Mucinous Neoplasms Li Z, Roth R, Rock JB, Lehman A, Marsh WL, Suarez A, Frankel WL

Carbonic anhydrase II: a novel biomarker for pseudomyxoma peritonei Järvinen P, Kivelä AJ, Nummela P, Lepistö A, Ristimäki A, Parkkila S

The modified Glasgow prognosis score predicts for overall and disease-free survival following cytoreductive surgery and HIPEC in patients with pseudomyxoma peritonei of appendiceal origin Tan GH, Novo CA, Dayal S, Chandrakumaran K, Mohamed F, Cecil T, Moran BJ

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study Hübner M, Teixeira Farinha H, Grass F, Wolfer A, Mathevet P, Hahnloser D, Demartines N

Outcomes of cytoreductive surgery and HIPEC for pseudomyxoma peritonei of appendiceal origin from two Indian centers: A preliminary five-year experience Bhatt A, Sheshadri D, Chandan G, Ramaswamy V, Pandey J, Bhorkar N, Agrawal D, Mehta S

A rare, low-grade appendiceal mucinous neoplasm (Pseudomyxoma peritonei) with ossification: A case report with morphoproteomic analysis of bone formation Noh B, Kim Y, Park Y

Radical appendectomy as an alternative to right colon resection in patients with epithelial appendiceal neoplasms González-Moreno S, Sugarbaker PH

External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix Milovanov V, Sardi A, Aydin N, Nieroda C, Sittig M, Gushchin V

Low-Grade Appendiceal Mucinous Neoplasm Presenting as an Adnexal Mass Panagopoulos P, Tsokaki T, Misiakos E, Domi V, Christodoulaki C, Sioutis D, Papantoniou N

Acute appendicitis, inflammatory appendiceal mass and the risk of a hidden malignant tumor: a systematic review of the literature Teixeira FJ Jr, Couto Netto SD, Akaishi EH, Utiyama EM, Menegozzo CA, Rocha MC

Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis Borazanci E, Millis SZ, Kimbrough J, Doll N, Von Hoff D, Ramanathan RK

Prognostic factors for survival in advanced appendiceal cancers Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E

Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination Huang Y, Alzahrani NA, Chua TC, Morris DL

Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC Schneider MA, Eshmuminov D, Lehmann K

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia Alzahrani N, Ferguson JS, Valle SJ, Liauw W, Chua T, Morris DL

Surgical management of appendiceal adenocarcinoid. Case report and literature review González-Sánchez-Migallón E, Valero-Navarro G, Sola-Pérez J, García-Marín J, Verdú-Fernández MÁ, Soria-Aledo V2, Aguayo-Albasini JL

Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study Rodríguez Silva C, Moreno Ruiz FJ, Bellido Estévez I, Carrasco Campos J, Titos García A, Ruiz López M, González Poveda I, Toval Mata JA, Mera Velasco S, Santoyo Santoyo J

Low-grade appendiceal mucinous neoplasm (LAMN) – 3-year endoscopic follow-up underlines benign course of LAMN type 1 Klag T, Wehkamp J, Bösmüller H, Falch C, Johannink J, Malek NP, Kirschniak 3, Goetz M

Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Saxena A, Valle SJ, Liauw W, Morris DL

Lymph Node Positivity in Appendiceal Adenocarcinoma: Should Size Matter? Gahagan JV, Whealon MD, Phelan MJ, Mills S, Pigazzi A, Stamos MJ, Nguyen NT, Carmichael JC

Management of an inguinal hernia in patients with pseudomyxoma peritonei Sugarbaker PH

*Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery Katz SC, Point GR, Cunetta M, Thorn M, Guha P, Espat NJ, Boutros C, Hanna N, Junghans RP

Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective Madalyn G. Neuwirth, H. Richard Alexander, Giorgos C. Karakousis

Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Milovanov V, Sardi A, Studeman K, Nieroda C, Sittig M, Gushchin V

Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, Shen P, Levine EA

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R

Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK

Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Dodson RM, McQuellon RP, Mogal HD, Duckworth KE, Russell GB, Votanopoulos KI, Shen P, Levine EA

Low-grade Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential (LAMN-UMP): Prognostic Factors and Implications for Treatment and Follow-up Fournier K, Rafeeq S, Taggart M, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R

Conditional Survival as a Patient Centered Metric for Patients with Appendiceal Adenocarcinoma Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS3, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM

Toward the molecular dissection of peritoneal pseudomyxoma Pietrantonio F, Perrone F, Mennitto A, Gleeson EM, Milione M, Tamborini E, Busico A, Settanni G, Berenato R, Caporale M, Morano F, Bossi I, Pellegrinelli A, Di Bartolomeo M, de Braud F, Baratti D, Bowne WB, Kusamura S, Deraco M

The relationship between diverticula and low-grade mucinous neoplasm of the appendix. Does the diverticulum play a role in the development of periappendicular mucin deposition or pseudomyxoma peritonei? Pasaoglu E, Leblebici C, Okcu O, Boyaci C, Dursun N, Hande Yardimci A, Kucukyilmaz M

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study Pietrantonio F, Berenato R, Maggi C, Caporale M, Milione M, Perrone F, Tamborini E, Baratti D, Kusamura S, Mariani L, Niger M, Mennitto A, Gloghini A, Bossi I, Settanni G, Busico A, Bagnoli PF, Di Bartolomeo M, Deraco M, de Braud F

Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Morris RS, Gani F, Hammad AY, Peltier W, Gamblin TC, Turaga KK, Johnston FM

Contrast-enhanced ultrasound improves accurate identification of appendiceal mucinous adenocarcinoma in an old patient: A case report Shang J, Ruan LT, Dang Y, Wang YY, Song Y, Lian J

Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study Sheffield BS, Tessier-Cloutier B, Li-Chang H, Shen Y, Pleasance E, Kasaian K, Li Y, Jones SJ, Lim HJ, Renouf DJ, Huntsman DG, Yip S, Laskin J, Marra M, Schaeffer DF

* Patient‐derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment Murali R. Kuracha, Peter Thomas, Brian W. Loggie, and Venkatesh Govindarajan

Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Ihemelandu C, Sugarbaker PH

Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM

Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis Widmann B, Warschkow R, Schmied B, Marti L, Steffen T

Intraperitoneal immunotherapy: historical perspectives and modern therapy Morano WF, Aggarwal A, Love P, Richard SD, Esquivel J, Bowne WB

Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia Alzahrani N, Ferguson JS, Valle SJ, Liauw W, Chua T, Morris DL

Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix Sparks DS , Morris B, Xu W, Fulton J, Atkinson V, Meade B, Lutton N

When and When Not to Perform a Right Colon Resection with Mucinous Appendiceal Neoplasms Sugarbaker PH

PTU-105 Cytoreductive Surgery and Small Bowel Transplantation is A Feasible Option for Patients with End-Stage Pseudomyxoma Peritonei P Allan, S Reddy, B Moran, G Vrakas, H Giele, F Mohamad, J Gilbert, S Sinha, A Vaidya, T Cecil, P Friend

Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies Shenoy S

Ultimate Clinical Outcomes of Appendiceal Mucinous Neoplasm of Uncertain Malignant Potential Shin R, Chai YJ, Park JW, Chang MS, Bae JM, Kim MJ, Park BK, Park KJ, Jeong SY

Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids Radomski M, Pai RK, Shuai Y, Ramalingam L, Jones H, Holtzman MP, Ahrendt SA, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study Baratti D, Kusamura S, Milione M, Pietrantonio F, Caporale M, Guaglio M, Deraco M

Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases Ihemelandu C, Mavros MN, Sugarbaker P

Two rare cases of appendiceal collision tumours involving an appendiceal mucinous neoplasm and carcinoid Tan HL, Tan GH, Teo M

Incidentally discovered low-grade appendiceal mucinous neoplasm: a precursor to pseudomyxoma peritonei Padmanaban V, Morano WF, Gleeson E, Aggarwal A, Mapow BL, Stein DE, Bowne WB

The Management and Prognostic Prediction of Adenocarcinoma of Appendix Xie X, Zhou Z, Song Y, Li W, Diao D, Dang C, Zhang H

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ

Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery? Liu Y, Mizumoto A, Ishibashi H, Takeshita K, Hirano M, Ichinose M, Takegawa S, Yonemura Y

Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume Surgeons Xie X, Zhou Z, Song Y, Li W, Diao D, Dang C, Zhang H

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours Maciver AH, Al-Sukhni E, Esquivel J, Skitzki JJ, Kane JM, Francescutti VA

Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis Widmann B, Warschkow R, Schmied B, Marti L, Steffen T

Precutting EMR for cecal tumors extending to the appendiceal orifice Imai K, Hotta K, Kakushima N, Ono H

Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review Nash GM, Smith JD, Tang L, Weiser MR, Temple LK, O’Reilly E, Saltz LB, Guillem JG, Paty PB

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF

Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study Baratti D, Kusamura S, Milione M, Pietrantonio F, Caporale M, Guaglio M, Deraco M

5-Aminolevulinic Acid Fluorescence in Detection of Peritoneal Metastases Yonemura Y, Canbay E, Ishibashi H, Nishino E, Endou Y, Sako S, Ogura S

Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms Choe JH1, Overman MJ, Fournier KF, Royal RE, Ohinata A, Rafeeq S, Beaty K, Phillips JK, Wolff RA, Mansfield PF, Eng C

The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A

Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed Kuijpers AM, Hauptmann M, Aalbers AG, Nienhuijs SW, de Hingh IH, Wiezer MJ, van Ramshorst B, van Ginkel RJ, Havenga K, Verwaal VJ

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ

Strategies for Preventing Pseudomyxoma Peritonei After Resection of a Mucinous Neoplasm of the Appendix Honoré C, Caruso F, Dartigues P, Benhaim L, Chirica M, Goéré D, Elias D

Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms Tuvin D, Berger Y, Aycart SN, Shtilbans T, Hiotis S, Labow DM, Sarpel U

Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis Widmann B, Warschkow R, Schmied B, Marti L, Steffen T

Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis Kehagias I, Zygomalas A, Markopoulos G, Papandreou T, Kraniotis P

Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei Tumours Ramaswamy V

The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases Bhatt A, Mehta S, Seshadri RA, Sethna K, Zaveri S, Rajan F, Mahajan V, Singh S, Raj EH, Sugarbaker PH

Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy Bhatt A, Mittal S, Gopinath KS

Intensive Care Management of Patient After Cytoreductive Surgery and HIPEC – A Concise Review Padmakumar AV

Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies Seshadri RA, Hemanth Raj E

Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases Mehta SS, Gelli M, Agarwal D, Goéré D

Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma Grotz TE, Mansfield PF, Royal RE, Mann GN, Rafeeq S, Beaty KA, Overman MJ, Fournier KF

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors Charrier T, Passot G, Peron J, Maurice C, Gocevska S, Quénet F, Eveno C, Pocard M, Goere D, Elias D, Ortega-Deballon P, Vaudoyer D, Cotte E, Glehen O

Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis Vassos N, Förtsch T, Aladashvili A, Hohenberger W, Croner RS

FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei Julien D, Francesco G, Pascal R, Naoual B, Guillaume P, Sylvie I, Olivier G, Andrea S

Retrospective analysis on the safety of 5,759 times of bedside hyperthermic intra-peritoneal or intra-pleural chemotherapy (HIPEC) Liu L, Zhang N, Min J, Su H, Wang H, Chen D, Sun L, Zhang H, Li W, Zhang H

Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future Dehal A, Smith JJ, Nash GM

Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy Low RN

Surgical technology and pharmacology of hyperthermic perioperative chemotherapy Sugarbaker PH, Van der Speeten K

Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Cummins KA, Russell GB, Votanopoulos KI, Shen P, Stewart JH, Levine EA

Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion Rajeev R, Klooster B, Turaga KK

Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy Lyon TD, Turner Ii RM, Nikonow TN, Wang L, Uy J, Ramalingam L, Holtzman MP, Pingpank JF, Bartlett DL, Davies BJ

Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? Tan GH1, Ong WS1, Chia CS1, Tham CK1, Soo KC1, Teo MCEA

Laparoscopic HIPEC: A bridge between open and closed-techniques Lotti M, Capponi MG, Piazzalunga D, Poiasina E, Pisano M, Manfredi R, Ansaloni L

Pseudomyxoma Peritonei: Symptom Control and Objective Radiological Response after Treatment with Lanreotide Autogel Zafra GM, Luque P

Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital’s initial experience and reflections on the health care system Naffouje SA, O’Donoghue C, Salti GI

Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility Chia CS,You B, Decullier E, Vaudoyer D,Lorimier G, Abboud K, Bereder JM, Arvieux C, Boschetti G,Glehen O,BIG RENAPE Group

Management of Appendix Cancer Kaitlyn J. Kelly, MD

Comparison of long-term oncological outcomes of appendiceal cancer and colon cancer: A multicenter retrospective study Son IT, Ahn S, Park KJ, Oh JH, Jeong SY, Park HC, Heo SC, Youk EG, Park JT, Ihn MH, Oh HK, Kim DW, Lee KH, Kang SB; Seoul Colorectal Group (SECOG)

The 7th Edition of the AJCC Staging Classification Correlates with Biologic Behavior of Mucinous Appendiceal Tumor with Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Milovanov V, Sardi A, Studeman K, Nieroda C, Sittig M, Gushchin V

Life after hyperthermic intraperitoneal chemotherapy; measuring quality of life and performance status after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapyr Ford J, Hanna M, Boston A, Berri R

* Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix Levine EA, Votanopoulos KI, Qasem SA, Philip J, Cummins KA, Chou JW, Ruiz J, D’Agostino R, Shen P, Miller LD

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus Liu Y, Ishibashi H, Hirano M, Takeshita K, Mizumoto A, Ichinose M, Nishino E, Kashu I, Yamamoto Y, Sugarbaker PH, Yonemura Y

A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy

Appendicular Mucocele: Possibilities and Limits of Laparoscopy. Brief Series and Review of the Literature Tărcoveanu E, Vasilescu A, Hee RV, Moldovanu R, Ursulescu C, Ciobanu D, Bradea C

BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis Willaert W, Van Der Speeten K, Liberale G, Ceelen W

Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei Kelly KJ,Baumgartner JM,Lowy AM

Appendiceal mixed adenoneuroendocrine carcinomas, a rare entity that can present as a Krukenberg tumor: case report and review of the literature Romeo M, Quer A, Tarrats A, Molina C, Radua J, Manzano JL

Clinicopathologic and Prognostic Features in Patients with Peritoneal Metastasis from Mucinous Adenocarcinoma, Adenocarcinoma with Signet Ring Cells, and Adenocarcinoid of the Appendix Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Ihemelandu C, Sugarbaker PH

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours Lansom J, Alzahrani N, Liauw W, Morris DL

Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei) Barrios P, Losa F, Gonzalez-Moreno S, Rojo A, Gómez-Portilla A, Bretcha-Boix P, Ramos I, Torres-Melero J, Salazar R, Benavides M, Massuti T, Aranda E

A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, Taflampas P, Chapman S, Moran BJ

Letter to the Editor With Regard to the Article Entitled: “A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritoneii and Associated Appendiceal Neoplasia Singhal, Shikha MBBS, MD; Giner-Segura, Francisco MD, PhD; Hompes, Roel MD; Guy, Richard MB, ChB, MD, FRCS; Wang, Lai Mun MB, BCh, MRCP, FRCPath

Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries Mogal HD, Levine EA, Russell G, Shen P, Stewart JH, Votanopoulos KI

Extensive surgical history prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with poor survival outcomes in patients with peritoneal mucinous carcinomatosis of appendiceal origin Milovanov V, Sardi A, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V

Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers Shaib WL, Martin LK, Choi M, Chen Z, Krishna K, Kim S, Brutcher E, Staley C 3rd, Maithel SK, Philip P, Abdel-Misih S, Bekaii-Saab TS, El-Rayes BF

Goblet cell appendiceal tumors–management dilemmas and long-term outcomes Rossi RE, Luong TV, Caplin ME, Thirlwell C, Meyer T, Garcia-Hernandez J, Baneke A, Conte D, Toumpanakis C

A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA

Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures Low RN, Barone RM, Lucero J

Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis Lam JY, McConnell YJ, Rivard JD, Temple WJ, Mack LA

* Targeting hypoxia-mediated mucin 2 production as a therapeutic strategy for mucinous tumors Dilly AK, Lee YJ, Zeh HJ, Guo ZS, Bartlett DL, Choudry HA

* Mitogen-activated protein kinase inhibition reduces mucin 2 production and mucinous tumor growth Dilly AK, Song X, Zeh HJ, Guo ZS, Lee YJ, Bartlett DL, Choudry HA

Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM

* Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines Darren L. Roberts, Sarah T. O’Dwyer, Peter L. Stern, Andrew G. Renehan

Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL

Systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with peritoneal mucinous carcinomatosis of appendiceal origin (PMCA) Milovanov V, Sardi A, Ledakis P, Aydin N, Nieroda C, Sittig M, Nunez M, Gushchin V

The Rise in Appendiceal Cancer Incidence: 2000-2009 Marmor S, Portschy PR, Tuttle TM, Virnig BA

A rare cause of ascites: pseudomyxoma peritonei and a review of the literature Abhishek Chauhan, Nishant Patodi, and Monz Ahmed

Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients Olsen I, Holt N, Langer SW, Hasselby JP, Grønbæk H, Hillingsø J, Mahmoud M, Ladekarl M, Iversen LH, Kjær A, Federspiel BH, Knigge U

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF

Elevated tumour markers are normalized in most patients with pseudomyxoma peritonei one week after complete tumour removal Di Fabio F, Aston W, Mohamed F, Chandrakumaran K, Cecil T, Moran B

Mucinous epithelial neoplasms of the appendix and pseudomyxoma peritonei Misdraji J

Cytological findings of appendiceal mixed adenoneuroendocrine carcinoma in pleural effusion: Morphological changes evident after metastasis Tonooka A, Oda K, Hayashi M, Sakazume K, Tanaka H, Kaburaki KH, Uekusa T

Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies Polanco PM, Ding Y, Knox JM, Ramalingam L, Jones H, Hogg ME, Zureikat AH, Holtzman MP, Pingpank J, Ahrendt S, Zeh HJ, Bartlett DL, Choudry HA

Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei Kusamura S, Moran BJ, Sugarbaker PH, Levine EA, Elias D, Baratti D, Morris DL, Sardi A, Glehen O, Deraco M; Peritoneal Surface Oncology Group International (PSOGI)

The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis Glockzin G, Gerken M, Lang SA, Klinkhammer-Schalke M, Piso P, Schlitt HJ

Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ

Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Patients with Diaphragmatic Involvement Franssen B, Tabrizian P, Weinberg A, Romanoff A, Tuvin D, Labow D, Sarpel U

* Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin Alakus H, Babicky ML, Ghosh P, Yost S, Jepsen K, Dai Y, Arias A, Samuels ML, Mose ES, Schwab RB, Peterson MR, Lowy AM, Frazer KA, Harismendy O

* Frequent lack of GNAS mutations in colorectal adenocarcinoma associated with GNAS-mutated villous adenoma Sekine S, Ogawa R, Oshiro T, Kanemitsu Y, Taniguchi H, Kushima R, Kanai Y

* FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma Pietrantonio F, Maggi C, Fanetti G, Iacovelli R, Di Bartolomeo M, Ricchini F, Deraco M, Perrone F, Baratti D, Kusamura S, Tamborini E, Castano A, Consonni PV, Bossi I, Gavazzi C, Milione M, Pelosi G, de Braud F

Predictors of Progression in High-Grade Appendiceal or Colorectal Peritoneal Carcinomatosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Baumgartner JM1, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM

GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival Singhi AD, Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Mantha G, Nikiforova M, Bartlett DL, Pai RK

Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations Liu X, Mody K, de Abreu FB, Pipas JM, Peterson JD, Gallagher TL, Suriawinata AA, Ripple GH, Hourdequin KC, Smith KD, Barth RJ Jr, Colacchio TA, Tsapakos MJ, Zaki BI, Gardner TB, Gordon SR, Amos CI, Wells WA, Tsongalis GJ

Significance of Proximal Margin Involvement in Low-Grade Appendiceal Mucinous Neoplasms Arnason T, Kamionek M, Yang M, Yantiss RK, Misdraji J

Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL

Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment Lohani K, Shetty S, Sharma P, Govindarajan V, Thomas P, Loggie B

Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, Votanopoulos K, Stewart JH, Shen P, Levine EA

Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites Randle RW, Swett KR, Swords DS, Shen P, Stewart JH, Levine EA, Votanopoulos KI

Pseudomyxoma peritonei: inflammatory responses in the peritoneal microenvironment Dohan A, Lousquy R, Eveno C, Goere D, Broqueres-You D, Kaci R, Lehmann-Che J, Launay JM, Soyer P, Bonnin P, Pocard M

Signifigance of signet ring cells in high-grade mucinous adenocarcinoma of the peritoneum from appendiceal origin Sirintrapun SJ, Blackham AU, Russell G, Votanopoulos K, Stewart JH, Shen P, Levine EA, Geisinger KR, Bergman S

Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations Liu X, Mody K, de Abreu FB, Pipas JM, Peterson JD, Gallagher TL, Suriawinata AA, Ripple GH, Hourdequin KC, Smith KD, Barth RJ Jr, Colacchio TA, Tsapakos MJ, Zaki BI, Gardner TB, Gordon SR, Amos CI, Wells WA, Tsongalis GJ

Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: Aspects of the learning curve Andréasson H, Lorant T, Påhlman L, Graf W, Mahteme H

Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) Votanopoulos KI, Randle RW, Craven B, Swett KR, Levine EA, Shen P, Stewart JH, Mirzazadeh M

Current concepts in pseudomyxoma peritonei Carr NJ

Peritoneal pseudomyxoma: An overview emphasizing pathological assessment and therapeutic strategies Dartigues P, Isaac S, Villeneuve L, Glehen O, Capovilla M, Chevallier A, Croce S, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F

The RENAPE network: Towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F

Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases Elias D, Goéré D, Dumont F, Honoré C, Dartigues P, Stoclin A, Malka D, Boige V, Ducreux M

Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients Taflampas P, Dayal S, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ

Whole abdominopelvic radiotherapy in the palliative treatment of pseudomyxoma peritonei Berkovic P, van de Voorde L, De Meerleer G, Delrue L, Speleers B, Van Belle S, Vandecasteele K

Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI

Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status Ihemelandu CU, McQuellon R, Shen P, Stewart JH, Votanopoulos K, Levine EA

Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA

* Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis Sio TT, Mansfield AS, Grotz TE, Graham RP, Molina JR, Que FG, Miller RC

Melphalan: A Promising Agent in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Sardi A, Jimenez W, Nieroda C, Sittig M, Shankar S, Gushchin V

Surgical Outcomes of Hyperthermic Intraperitoneal Chemotherapy: Analysis of the American College of Surgeons National Surgical Quality Improvement Program Jafari MD, Halabi WJ, Stamos MJ, Nguyen VQ, Carmichael JC, Mills SD, Pigazzi A

HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy McConnell YJ, Mack LA, Francis WP, Ho T, Temple WJ

Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival Shetty S, Natarajan B, Thomas P, Govindarajan V, Sharma P, Loggie B

The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer Jimenez WA, Sardi A, Ledakis P, Nieroda C, Sittig M, Gushchin V

Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V

*Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms Nishikawa G, Sekine S, Ogawa R, Matsubara A, Mori T, Taniguchi H, Kushima R, Hiraoka N, Tsuta K, Tsuda H, Kanai Y

A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei Pillai K, Akhter J, Chua TC, Morris DL

Quality of Life Study following Cytoreductive Surgery and Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei including Redo Procedures Rachel Kirby, Winston Liauw, Jing Zhao, and David Morris

Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA

Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy Koh JL, Liauw W, Chua T, Morris DL

A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A, Lazinski DW, Camilli A, Testerman TL, Merrell DS

Antibiotic Treatment Decreases Microbial Burden Associated with Pseudomyxoma Peritonei and Affects β-catenin Distribution Semino-Mora C, Testerman TL, Liu H, Whitmire JM, Studeman K, Jia Y, McAvoy TJ, Francis J, Nieroda C, Sardi A, Merrell DS, Dubois A

The incidence of mucinous appendiceal malignancies: a population-based study van den Heuvel MG, Lemmens VE, Verhoeven RH, de Hingh IH

Extensive Cytoreductive Surgery for Appendiceal Carcinomatosis: Morbidity, Mortality, and Survival Wagner PL, Austin F, Maduekwe U, Mavanur A, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA

Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei Choudry HA, Mavanur A, O’Malley ME, Zeh HJ, Guo Z, Bartlett DL

Mucin as a therapeutic target in pseudomyxoma peritonei Choudry HA, O’Malley ME, Guo ZS, Zeh HJ, Bartlett DL

* Life after death: targeting high mobility group box 1 in emergent cancer therapies Z Sheng Guo, Zuqiang Liu, David L Bartlett, Daolin Tang, and Michael T Lotze

Current status and future directions in appendiceal cancer with peritoneal dissemination Votanopoulos KI, Shen P, Stewart JH 4th, Levine EA

Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review Sree Harsha Tirumani, Margaret Fraser-Hill, Rebecca Auer, Wael Shabana, Cynthia Walsh, Frank Lee, and John G. Ryan

Significance of Serum Tumor Marker Levels in Peritoneal Carcinomatosis of Appendiceal Origin Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, Jones HL, Holtzman MP, Ahrendt SA, Zureikat AH, Pingpank JF, Zeh HJ 3rd, Bartlett DL, Choudry HA

Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival Bijelic L, Kumar AS, Stuart OA, Sugarbaker PH

Quality of Life in Patients after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is It Worth the Risk? Tsilimparis N, Bockelmann C, Raue W, Menenakos C, Perez S, Rau B, Hartmann J

Delay of cytoreductive surgery and heated intraperitoneal chemotherapy in patients with appendiceal neoplasm El Halabi H, Macdonald R, Studeman K, Francis J, Nieroda C, Gushchin V, Sardi A

Inflammatory Markers in Blood and Serum Tumor Markers Predict Survival in Patients With Epithelial Appendiceal Neoplasms Undergoing Surgical Cytoreduction and Intraperitoneal Chemotherapy Chua TC, Chong CH, Liauw W, Zhao J, Morris DL

Pseudomyxoma peritonei of 92 Chinese patients: Clinical characteristics, pathological classification and prognostic factors Ai-Tao Guo, Yan-Mi Li, Li-Xin Wei

Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases Carr NJ, Finch J, Ilesley IC, Chandrakumaran K, Mohamed F, Mirnezami A, Cecil T, Moran B

Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA

Mucin as a therapeutic target in pseudomyxoma peritonei Sugarbaker PH, Stuart OA, Eger C

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication Choudry HA, O’Malley ME, Guo ZS, Zeh HJ, Bartlett DL

Classification of and cytoreductive surgery for low-grade appendiceal mucinous neoplasms McDonald JR, O’Dwyer ST, Rout S, Chakrabarty B, Sikand K, Fulford PE, Wilson MS, Renehan AG

Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Königsrainer I, Zieker D, Glatzle J, Lauk O, Klimek J, Symons S, Brücher B, Beckert S, Königsrainer A

A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C Votanopoulos K, Ihemelandu C, Shen P, Stewart J, Russell G, Levine EA

No-incision (NOTES) versus single-incision (single-port) surgery for access to sites of peritoneal carcinomatosis: a back-to-back animal study Ladjici Y, Pocard M, Marteau P, Valleur P, Dray X

Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI Klumpp BD, Schwenzer N, Aschoff P, Miller S, Kramer U, Claussen CD, Bruecher B, Koenigsrainer A, Pfannenberg C

Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy Casado-Adam A, Alderman R, Stuart OA, Chang D, Sugarbaker PH

Addition of Biological Therapies to Palliative Chemotherapy Prolongs Survival in Patients With Peritoneal Carcinomatosis of Colorectal Origin Klaver YL, Leenders BJ, Creemers GJ, Rutten HJ, Verwaal VJ, Lemmens VE, de Hingh IH

CT imaging interval after complete cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (HIPEC) for well-differentiated adenocarcinoma of the appendix (WDAA) Karen A. Beaty, Joshua S. Hill, Safia Rafeeq, Michael J. Overman, Tara L. Sagebiel, Aurelio Matamoros, Richard E. Royal, Paul F. Mansfield, Keith F. Fournier; University of Texas M. D. Anderson Cancer Center, Houston, TX

Early and long-term outcome data on 2,298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Terence C. Chua, Brendan J. Moran, Paul H. Sugarbaker, Edward Allen Levine, Olivier Glehen, Francois N. Gilly, Dominique Elias, Dario Baratti, Marcello Deraco, Armando Sardi, David L. Morris, Peritoneal Surface Oncology Group International; University of New South Wales, Sydney, Australia; NCG Pseudomyxoma Peritonei Centre, The North Hampshire Hospital, Basingstoke, United Kingdom; Washington Hospital Center, Washington, DC; Wake Forest School of Medicine, Winston-Salem, NC; Centre Hospitalo-Universitaire Lyon Sud, Lyon, France; Institut Gustave Roussy, Villejuif, France; Istituto Nazionale per la Cura e lo Studio dei Tumori , Milan, Italy; Mercy Medical Center, Baltimore, MD

Impact of tumor aneuploidy in pseudomyxoma peritonei Shreya Jagadish Shetty, Bala Natarajan, Brian W. Loggie; Creighton University Medical Center, Omaha, NE

Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH Protein Andréasson H, Wanders A, Sun XF, Willén R, Graf W, Nygren P, Glimelius B, Zhang ZY, Mahteme H

The Influence of Tumor Cell Entrapment Phenomenon on the Natural History of Pseudomyxoma peritonei Syndrome Spiliotis J, Efstathiou E, Halkia E, Vaxevanidou A, Datsis A, Sugarbaker P

Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies Kusamura S, Baratti D, Deraco M

Flexible versus rigid single-port peritoneoscopy: a randomized controlled trial in a live porcine model followed by initial experience in human cadavers Ladjici Y, Dray X, Marteau P, Valleur P, Pocard M

Critical role of hyperthermic intraperitoneal chemoperfusion in the treatment of a patient with Pseudomyxoma peritonei Cole KL, Choudry HA, Jones HL, Goodell PP, Bartlett DL

Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei Foster JM, Gupta PK, Carreau JH, Grotz TE, Blas JV, Gatalica Z, Nath S, Loggie BW

Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–Overview and Basics Brücher BL, Piso P, Verwaal V, Esquivel J, Derraco M, Yonemura Y, Gonzalez-Moreno S, Pelz J, Königsrainer A, Ströhlein M, Levine EA, Morris D, Bartlett D, Glehen O, Garofalo A, Nissan A

Gene Expression Profiling of Peritoneal Metastases from Appendiceal and Colon Cancer Demonstrates Unique Biologic Signatures and Predicts Patient Outcomes Levine EA, Blazer DG 3rd, Kim MK, Shen P, Stewart JH 4th, Guy C, Hsu DS

Immunohistochemical and biochemical characterization of mucin in pseudomyxoma peritonei: a case study Mall AS, Lotz Z, Tyler M, Goldberg P, Rodrigues J, Kahn D, Chirwa N, Govender D

Pharmacokinetic study of perioperative intravenous Ifosfamide Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH

Mucolysis by Ascorbic Acid and Hydrogen Peroxide on Compact Mucin Secreted in Pseudomyxoma Peritonei Pillai K, Akhter J, Chua TC, Morris DL

Multidimensional Analysis of Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies Kusamura S, Baratti D, Deraco M

Multimodal Treatment Approaches for Peritoneal Carcinomatosis in Colorectal Cancer Piso P, Arnold D

Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer Ströhlein MA, Bulian DR, Heiss MM

Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging Iafrate F, Ciolina M, Sammartino P, Baldassari P, Rengo M, Lucchesi P, Sibio S, Accarpio F, Di Giorgio A, Laghi A

Mucinous neoplasms of the appendix and peritoneum Panarelli NC, Yantiss RK

Cancers of the Appendix: Review of the Literatures Carl Ruoff, Louay Hanna, Wanqing Zhi, Ghulamullah Shahzad, Vladimir Gotlieb, and Muhammad Wasif Saif

Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, Schiller D

Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice Dai M, Xu X, Song J, Fu S, Gou M, Luo F, Qian Z

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial Deraco M, Kusamura S, Virzì S, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Iusco DR, Baratti D

Cytoreductive surgery with intraperitoneal chemotherapy to treat pseudomyxoma peritonei at nonspecialized hospitals Kitai T, Kawashima M, Yamanaka K, Ichijima K, Fujii H, Mashima S, Shimahara Y

Appendiceal adenocarcinoids with peritoneal carcinomatosis treated with cytoreductive surgery and intraperitoneal chemotherapy: a retrospective study of in vitro drug sensitivity and survival Cashin P, Nygren P, Hellman P, Granberg D, Andréasson H, Mahteme H

Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome Chua TC, Liauw W, Morris DL

Cytoreductive surgery and HIPEC in peritoneal recurrent ovarian cancer: experience and lessons learned Königsrainer I, Beckert S, Becker S, Zieker D, Fehm T, Grischke EM, Lauk O, Glatzle J, Brücher B, Wallwiener D, Königsrainer A

Endoscopic ultrasound-guided fine needle aspiration of peritoneal nodules in patients with ascites of unknown cause Rana SS, Bhasin DK, Srinivasan R, Singh K

Management of peritoneal carcinomatosis from colorectal cancer Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA

Factors influencing early postoperative recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Arakelian E, Gunningberg L, Larsson J, Norlén K, Mahteme H

Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis Klaver YL, Chua TC, de Hingh IH, Morris DL

Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart M, Fournier K, Royal R, Mansfield P, Overman MJ

Patients with high-grade appendix cancer and extensive disease do benefit from Cytoreduction and heated intraperitoneal chemotherapy if complete cytoreduction can be achieved H.M. El Halabi, V. Gushchin, R. Macdonald, J. Francis, A. Sardi

Lymph node metastasis predicts survival in patients with highgrade appendix cancer H.M. El Halabi, V. Gushchin, R. Macdonald, J. Francis, N. Athas, A. Sardi

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial Deraco M, Kusamura S, Virzì S, Puccio F, Macrì A, Famulari C, Solazzo M, Bonomi S, Iusco DR, Baratti D

Reappraisal of the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer: a single institutional experience Melis A, Abboud K, Bourmaud A, Pacaut C, Bageacu S, Jacquin JP, Porcheron J, Merrouche Y, Magné N

Bologna Guidelines for Diagnosis and Management of Adhesive Small Bowel Obstruction (ASBO): 2010 Evidence-Based Guidelines of the World Society of Emergency Surgery Catena F, Di Saverio S, Kelly MD, Biffl WL, Ansaloni L, Mandalà V, Velmahos GC, Sartelli M, Tugnoli G, Lupo M, Mandalà S, Pinna AD, Sugarbaker PH, Van Goor H, Moore EE, Jeekel J

Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis Sugarbaker PH, Van der Speeten K, Anthony Stuart O, Chang D

Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients Chua TC, Al-Alem I, Saxena A, Liauw W, Morris DL

Peritoneal carcinomatosis from appendiceal cancer: early adequate therapeutic management for long-term survival Glehen O, Bakrin N, Passot G

Rationale for Heating Oxaliplatin for the Intraperitoneal Treatment of Peritoneal Carcinomatosis: A Study of the Effect of Heat on Intraperitoneal Oxaliplatin Using a Murine Model Piché N, Leblond FA, Sidéris L, Pichette V, Drolet P, Fortier LP, Mitchell A, Dubé P

Hyperthermia and Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis: An Experimental Study Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH

Feasibility of Delayed Hyperthermic Intraperitoneal Chemotherapy in Case of Unforeseen Complications Mohr Z, Hirche C, Liebeskind U, Rau B, Hünerbein M

Primary appendiceal mucinous adenocarcinoma in two first-degree relatives: case report and review Racek AR Msii, Rabe KG M S, Wick MJ M D Ph D, Psychogios A M D, Lindor NM M D

Long-term follow-up in the treatment of peritoneal carcinomatosis Hamilton T, Lanuke K, Mack LA, Temple WJ

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study Tang L, Mei LJ, Yang XJ, Huang CQ, Zhou YF, Yonemura Y, Li Y

A new standard of care for the management of peritoneal surface malignancy Mohamed F, Cecil T, Moran B, Sugarbaker P

Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre Arjona-Sánchez A, Muñoz-Casares FC, Rufián-Peña S, Díaz-Nieto R, Casado-Adam A, Rubio-Pérez MJ, Ortega-Salas R

Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate Chua TC, Liauw W, Zhao J, Morris DL

Unresectable peritoneal carcinomatosis from colorectal cancer: A single center experience Hompes D, Boot H, van Tinteren H, Verwaal V

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y

Closed Abdomen Hyperthermic Intraperitoneal Chemotherapy with Irinotecan and Mitomycin C: a Phase I Study Cotte E, Passot G, Tod M, Bakrin N, Gilly FN, Steghens A, Mohamed F, Glehen O

Netrin-4 Delays Colorectal Cancer Carcinomatosis by Inhibiting Tumor Angiogenesis Eveno C, Broqueres-You D, Feron JG, Rampanou A, Tijeras-Raballand A, Ropert S, Leconte L, Levy BI, Pocard M

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy Klaver YL, de Hingh IH, Boot H, Verwaal VJ

Literature review of the efficacy and safety of hyperthermic intraperitoneal perfusion chemotherapy after cytoreductive surgery in the treatment of pseudomyxoma peritonei Ba MC, Cui SZ, Luo FT, Ouyang WW, Tang YQ, Wu YB, Tang HS

Ultrasonography findings and tumour quantification in patients with pseudomyxoma peritonei Krause J, Bergman A, Graf W, Nilsson A, Mahteme H

Childbearing After Hyperthermic Intraperitoneal Chemotherapy: Results From an International Survey Ortega-Deballon P, Glehen O, Levine E, Piso P, Sugarbaker PH, Hayes-Jordan A, Facy A, Bakrin N, Rat P

Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ

On or in the liver? Two cases with diffuse pseudomyxoma peritonei and synchronous hepatic pathology Youssef H, Moran BJ

Determining the Association Between Preoperative Computed Tomography Findings and Postoperative Outcomes After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL

Influence of Modern Systemic Therapies as Adjunct to Cytoreduction and Perioperative Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis: A Multicenter Study Chua TC, Morris DL, Saxena A, Esquivel J, Liauw W, Doerfer J, Germer CT, Kerscher AG, Pelz JO

Goblet cell carcinoid tumors of the appendix: An overview Paromita Roy and Runjan Chetty

Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC Ross A, Sardi A, Nieroda C, Merriman B, Gushchin V

Revised guidelines for second-look surgery in patients with colon and rectal cancer Sugarbaker PH

Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study Esquivel J, Chua TC, Stojadinovic A, Melero JT, Levine EA, Gutman M, Howard R, Piso P, Nissan A, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Shen P, Stewart JH, Sugarbaker PH, Barone RM, Hoefer R, Morris DL, Sardi A, Sticca RP

Pharmacology of perioperative 5-fluorouracil Van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH

Use of FDG-PET imaging for patients with disseminated cancer of the appendix Rohani P, Scotti SD, Shen P, Stewart JH, Russell GB, Cromer M, Levine EA

Indication of Peritonectomy for Peritoneal Dissemination Yonemura Y, Tsukiyama G, Miyata R, Sako S, Endou Y, Hirano M, Mizumoto A, Matsuda T, Takao N, Ichinose M, Miura M, Hagiwara A, Li Y

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy Klaver YL, de Hingh IH, Boot H, Verwaal VJ

Selection of patients and staging of peritoneal surface malignancies Eddy Cotte, Guillaume Passot, François-Noël Gilly, and Olivier Glehen

New approach to peritoneal surface malignancies Antonio Macrì, Department of Human Pathology, General Surgery Unit, University of Messina, 98125 Messina, Italy

Clinical presentation of pseudomyxoma peritonei Järvinen P, Lepistö A. Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O Cavaliere F, De Simone M, Virzì S, Deraco M, Rossi CR, Garofalo A, Di Filippo F, Giannarelli D, Vaira M, Valle M, Pilati P, Perri P, La Pinta M, Monsellato I, Guadagni F. Department of Surgery, San Giovanni Hospital, Via dell’Amba Aradam 9, 00184 Rome, Italy

Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer Sugarbaker PH, Van der Speeten K, Stuart OA

Pseudomyxoma peritonei Katharine E Bevan, Faheez Mohamed and Brendan J Moran

Appendiceal mucinous neoplasms: controversial isses Misdraji J

Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases Ira Winer and Ronald J. Buckanovich

A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy Tristan D Yan, Christopher Qian Cao and Stine Munkholm-Larsen

Peritoneal-based malignancies and their treatment Teo M

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy Elias D, Gilly F, Quenet F, Bereder JM, Sidéris L, Mansvelt B, Lorimier G, Glehen O; Association Française de Chirurgie

A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin Bruin SC, Verwaal VJ, Vincent A, van’t Veer LJ, van Velthuysen ML

Surgical responsibilities in the management of peritoneal carcinomatosis Sugarbaker PH

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ 3rd

Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends Maggiori L, Elias D

Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy Winder T, Lenz HJ

Prospective study of quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using oxaliplatin for peritoneal carcinomatosis Lim C, Tordjmann D, Gornet JM, Nemeth J, Valleur P, Pocard M

Secondary Cytoreduction and Perioperative Intraperitoneal Chemotherapy after Initial Debulking of Pseudomyxoma Peritonei: A Study of Timing and the Impact of Malignant Dedifferentiation Chua TC, Al-Zahrani A, Saxena A, Liauw W, Zhao J, Morris DL

Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1290 patients Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D; the French Surgical Association

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH

Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy Chua TC, Liauw W, Saxena A, Al-Mohaimeed K, Fransi S, Zhao J, Morris DL

Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, Lorimier G, Dubè P, Glehen O

Epithelial appendiceal neoplasms Sugarbaker PH

Laparoscopic Mucin Removal in Patients With Pseudomyxoma Peritonei Albedah, A

Simultaneous bicavitary hyperthermic chemoperfusion in the management of pseudomyxoma peritonei with synchronous pleural extension Senthil M, Harrison LE

Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology Omohwo C, Nieroda CA, Studeman KD, Thieme H, Kostuik P, Ross AS, Holter DR, Gushchin V, Merriman B, Sardi A

Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience Shapiro JF, Chase JL, Wolff RA, Lambert LA, Mansfield PF, Overman MJ, Ohinata A, Liu J, Wang X, Eng C

Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings–a feasibility study Low RN, Sebrechts CP, Barone RM, Muller W

Comprehensive management of peritoneal surface malignancy using cytoreductive surgery and perioperative intraperitoneal chemotherapy: the Washington Cancer Institute approach Sugarbaker PH

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience Vaira M, Cioppa T, DE Marco G, Bing C, D’Amico S, D’Alessandro M, Fiorentini G, DE Simone M

Incidence, Risk Factors, and Impact of Severe Neutropenia After Hyperthermic Intraperitoneal Mitomycin C Lambert, Laura A.; Armstrong, Terri S.; Lee, J. Jack; Liu, Suyu; Katz, Matthew H.; Eng, Cathy;et. al

In vivo model of pseudomyxoma peritonei for novel candidate drug discovery Chua TC, Akther J, Yao P, Morris DL

Primary peritonectomy/HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures Zhu KJ, Morris DL

Pseudomyxoma Peritonei: A Need to Establish Evidence-Based Standard of Care—Is This the Right Trial? Terence C. Chua, BScMed (Hons), Khaled Al-Mohaimeed, MBBS, FRCS, Winston Liauw, MBBS, FRACP, and David L. Morris, MD, PhD

Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine Sun WL, Hutarew G, Gradl J, Gratzl M, Denz H, Fiegl M

A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Lanuke K, Mack LA, Temple WJ

Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei) Moran B, Baratti D, Yan TD, Kusamura S, Deraco M

Appendiceal neoplasms and pseudomyxoma peritonei: a population based study Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA

Pseudomyxoma Peritonei: Is Disease Progression Related to Microbial Agents? A Study of Bacteria, MUC2 and MUC5AC Expression in Disseminated Peritoneal Adenomucinosis and Peritoneal Mucinous Carcinomatosis Cristina Semino-Mora, Hui Liu, Thomas McAvoy, Carol Nieroda, Kimberley Studeman, Armando Sardi, and Andre Dubois

Peritoneal Pseudomyxoma: Results of a Systematic Policy of Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, Dromain C, Duvillard P, Goéré D

A Phase II Study Evaluating the Use of Concurrent Mitomycin C and Capecitabine (Xeloda) in Patients with Advanced Unresectable Pseudomyxoma Peritonei Farquharson AL, Pranesh N, Witham G, Swindell R, Taylor MB, Renehan AG, Rout S, Wilson MS, O’Dwyer ST, Saunders MP

Mucinous Ovarian Tumors Associated with Pseudomyxoma Peritonei of Adenomucinosis Type: Immunohistochemical Evidence That They Are Secondary Tumors Ferreira CR, Carvalho JP, Soares FA, Siqueira SA, Carvalho FM

Quality of Life After Cytoreductive Surgery plus Early Intraperitoneal Postoperative Chemotherapy for Pseudomyxoma Peritonei – A Prospective Study Jess P, Iversen LH, Nielsen MB, Hansen F, Laurberg S, Rasmussen PC

Retrospective Multicenter Study of a Clinicopathological Analysis of Pseudomyxoma Peritonei Associated with Ovarian Tumors (KGOG 3005) Lee JK, Song SH, Kim I, Lee KH, Kim BG, Kim JW, Kim YT, Park SY, Cha MS, Kang SB

Successful pregnancy in a patient with pseudomyxoma peritonei following in-vitro fertilization using donor eggs SA Narvekar, PK VijayKumar, N Shetty, MS Srinivas, and KA Rao

Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei Cioppa T, Vaira M, Bing C, D’Amico S, Bruscino A, De Simone M

Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei Cioppa T, Vaira M, Bing C, D’Amico S, Bruscino A, De Simone M

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, Daniel S, de Bree E, Deraco M, Dominguez-Parra L, Elias D, Flynn R, Foster J, Garofalo A, Gilly FN, Glehen O, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Goodman M, Gushchin V, Hanna N, Hartmann J, Harrison L, Hoefer R, Kane J, Kecmanovic D, Kelley S, Kuhn J, Lamont J, Lange J, Li B, Loggie B, Mahteme H, Mann G, Martin R, Misih RA, Moran B, Morris D, Onate-Ocana L, Petrelli N, Philippe G, Pingpank J, Pitroff A, Piso P, Quinones M, Riley L, Rutstein L, Saha S, Alrawi S, Sardi A, Schneebaum S, Shen P, Shibata D, Spellman J, Stojadinovic A, Stewart J, Torres-Melero J, Tuttle T, Verwaal V, Villar J, Wilkinson N, Younan R, Zeh H, Zoetmulder F, Sebbag G; Society of Surgical Oncology Annual Meeting

HIPEC: The Complexities of Clinical Trials Bartlett, D

Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Robert M. Smeenk, MD, Vic J. Verwaal, MD, PhD, Ninja Antonini, MSc, and Frans A. N. Zoetmulder, MD, PhD

A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Yan TD, Black D, Savady R, Sugarbaker PH

Mucinous Appendiceal Neoplasms: Preoperative MR Staging and Classification Compared with Surgical and Histopathologic Findings Russell N. Low, Robert M. Barone, Jonathan M. Gurney, and Wayne D. Muller

HIPEC with Oxaliplatin in the Treatment of Peritoneal Carcinomatosis of Colorectal Origin D Elias, M Pocard, D Goere

Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms Yan TD, Bijelic L, Sugarbaker PH

Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M

Progression of Pseudomyxoma Peritonei after Combined Modality Treatment: Management and Outcome Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA

Learning curve of combined modality treatment in peritoneal surface disease Smeenk RM, Verwaal VJ, Zoetmulder FA

Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm Murphy EM, Sexton R, Moran BJ

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms Yan TD, Links M, Xu ZY, Kam PC, Glenn D, Morris DL

Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma Yan TD, Black D, Savady R, Sugarbaker PH

Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy Tristan D Yan, Oswald A Stuart, Dal Yoo and Paul H Sugarbaker

New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Paul H Sugarbaker

Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy Stewart JH 4th, Shen P, Russell GB, Bradley RF, Hundley JC, Loggie BL, Geisinger KR, Levine EA

COX – 2 Expression in Pseudomyxoma Peritonei Gatalica Z, Loggie B

Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR

High Expression of RELP (Reg IV) in Neoplastic Goblet Cells of Appendiceal Mucinous Cystadenoma and Pseudomyxoma Peritonei Heiskala K, Giles-Komar J, Heiskala M, Andersson LC

A Specific Cadherin Phenotype May Characterize the Disseminating Yet Non-Metastatic Behavior of Pseudomyxoma Peritonei Bibi R, Pranesh N, Saunders MP, Wilson MS, O’dwyer ST, Stern PL, Renehan AG

Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy González-Moreno S, Brun E, Sugarbaker PH

Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer Rhonda L Harmon and Paul H Sugarbaker

Are There Curative Options to Peritoneal Carcinomatosis? Paul H. Sugarbaker, MD, FACS, FRCS

Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence Alexander-Sefre F, Chandrakumaran K, Banerjee S, Sexton R, Thomas JM, Moran B

Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions Stewart JH 4th, Shen P, Levine EA

Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence Mukherjee A, Parvaiz A, Cecil TD, Moran BJ

Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding González-Moreno S, Sugarbaker PH

Clinically Aggressive Pseudomyxoma Peritonei: A Variant of a Histologically Indolent Process Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH

Elevated Tumour Markers Prior to Complete Tumour Removal in Patients with Pseudomyxoma Peritonei Predict Early Recurrence F. Alexander-Sefre, K. Chandrakumaran, S. Banerjee, R. Sexton, J. M. Thomas

Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S

Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy Glehen O, Mohamed F, Sugarbaker PH

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Güner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P

Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study Glehen O,
Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y,
Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J,
Gomez-Portilla A, Shen P, Deraco M, Rat P

Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence Mukherjee A, Parvaiz A, Cecil TD, Moran BJ

Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding González-Moreno S, Sugarbaker PH

Clinically Aggressive Pseudomyxoma Peritonei: A Variant of a Histologically Indolent Process Mohamed F, Gething S, Haiba M, Brun EA, Sugarbaker PH

Elevated Tumour Markers Prior to Complete Tumour Removal in Patients with Pseudomyxoma Peritonei Predict Early Recurrence F. Alexander-Sefre, K. Chandrakumaran, S. Banerjee, R. Sexton, J. M. Thomas

Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S

Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy Glehen O, Mohamed F, Sugarbaker PH

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei Güner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P

Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O

Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study Glehen O, Kwiatkowski F, Sugarbaker PH, Elias D, Levine EA, De Simone M, Barone R, Yonemura Y, Cavaliere F, Quenet F, Gutman M, Tentes AA, Lorimier G, Bernard JL, Bereder JM, Porcheron J, Gomez-Portilla A, Shen P, Deraco M, Rat P

Scientific research is extremely important in improving the treatment and curability of PMP, appendix cancer, and related peritoneal surface malignancies. Following are some of the pertinent research studies that have been published from 2004 to present.

* Research marked with an asterisk was partially or wholly funded by an ACPMP Research Grant

Previous Next
Close
Test Caption
Test Description goes like this